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ABSTRACT
Gutwein, Amanda Brooke. M.S., Department of Neuroscience, Cell Biology and
Physiology, Wright State University, 2013. Characterization of stimulation-induced
volume changes of the CA1 region within in vitro rat hippocampus slices.
Intrinsic optical signals (IOS) were used to evaluate volume regulation
mechanisms during Schaffer collateral stimulation-induced volume changes in
hippocampal slices. The effects of stimulation frequency, synaptic function, ionotropic
glutamate receptor (iGluR) activation, glutamate uptake, and volume regulatory anion
channels (VRAC) were examined with IOS. Data were analyzed using ANOVA with
Dunnett's post hoc test (p<0.05 indicated significance). IOS changes were stimulation
frequency dependent between 1 Hz and 10 Hz with full recovery of IOS within 5 min.
Synaptic blockage reduced the rate of swelling by 81% compared to the control and the
IOS did not fully recover. Recovery rate was reduced with iGluR inhibition. Inhibition of
glutamate uptake reduced the rate of swelling by 70% compared to vehicle controls.
During stimulation, action potentials, iGluR activation, and glutamate uptake contribute
to swelling. Regulatory volume mechanisms during stimulation were glutamate-mediated
via iGluRs and VRAC independent.
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I. INTRODUCTION
Regulation of cellular volume is a vital aspect of cellular homeostasis. Cells are
susceptible to volume changes when there are fluctuations in intracellular and
extracellular osmolarity. Cell volume is determined by the cellular content of osmotic
active compounds and by the extracellular tonicity. Cell water content will change based
on the osmotic active compounds present. As the intracellular content of osmotic active
compounds increases, the extracellular space becomes hypotonic to the cell, and the cells
take in water in an attempt to equalize the osmotic pressure. During hypoosmotic cell
swelling, an acute increase in cellular volume is restored through a mechanism termed
regulatory volume decrease (RVD) by the efflux of inorganic and organic osmolytes.
This mechanism decreases the intracellular osmotic content thus increasing the
movement of water from the intracellular compartment. Osmolyte efflux is accomplished
via activation of specific transporters and volume-activated channels. Volume-regulated
anion channels (VRACs) open during cell swelling and mediate RVD. VRACs are anion
channels which are permeable to chloride and a variety of small organic anions such as
taurine and excitatory amino acids (EAA) like glutamate (Kimelberg et al., 1990).
Previous studies have reported stimulation-induced swelling in the central
nervous system; however, mechanisms of cell swelling and volume regulation during
functional activity remain unclear. Many factors have been suggested to be involved in
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neuronal activity induced cell swelling including fluctuations of extracellular K+,
glutamate accumulation in astrocytes, and activation of ionotropic glutamate receptor
(iGluR). The proposed research is intended to identify and characterize the features of
stimulation-induced volume changes of the rat hippocampus through the application of a
synaptic block solution, iGluR antagonists, glutamate reuptake inhibitors, and VRAC
inhibitors. In this study, we will use imaging analysis techniques to examine changes in
the light transmission (intrinsic optical signal or IOS) of hippocampal slices induced by
synaptic transmission. Although it is accepted that IOS can detect cellular swelling by
increased light transmittance through tissue, the cellular mechanisms underlying these
changes in the IOS of neuronal tissue during activity are not precisely known as yet.
Synaptic activation or moderate hypo-osmotic exposure has been shown to lead to
increased light transmittance, decreased reflectance, and reduced light scattering
(MacVicar and Hochman, 1991; Andrew and MacVicar, 1994; Pal et al., 2013). A
decrease in extracellular space (ECS) has been shown to occur during evoked activity in
the cortex (Dietzel et al., 1982) in stimulated spinal cord slices(Sykova et al., 2003) and
in the hippocampal slice during synaptic stimulation (Fayuk et al., 2002).
A greater understanding of the mechanisms and osmolytes responsible for
stimulation-induced swelling will lead to improved treatment plans for any
pathophysiological conditions resulting in edema such as epilepsy, traumatic brain injury,
and excitotoxicity.
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II. LITERATURE REVIEW
Fluid movement in the brain
In the central nervous system (CNS), fluid in different compartments is regulated
through specialized cellular membranes. The movement of fluid between compartments
of blood, cerebrospinal fluid, extracellular fluid, and intracellular fluid of neurons and
glia depends on the concentrations of inorganic and organic osmolytes. There is
presumably a continuous flux of water between neurons and glial cells because of cellular
transport of osmolytes such as glutamate, sodium, and potassium between these cell types
(Kimelberg, 2004a). Abnormal water movements between these compartments are
associated with numerous pathological conditions including stroke, brain tumors,
traumatic brain injury and temporal lobe epilepsy (Unterberg et al., 2004; van Vliet et al.,
2007; Freeman et al., 2010; Thompson et al., 2013).
Edema
Cerebral edema is characterized by an excess of fluid accumulation in the brain.
Edema is a common pathological response to various forms of neurologic insults that
affect patients with almost every category of neurologic disease, including metabolic,
infectious, neoplastic, cerebrovascular, and traumatic brain injury disease states (Ryu et
al., 2013). Following neurological insult, alterations in osmolyte gradients drive fluid
accumulation and increase brain volume. The excess fluid deforms the brain tissue that is
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restricted by the meningeal layers and skull causing an increased intracranial pressure and
resulting in a high rate of morbidity and mortality.
Brain edema is classified as osmotic, vasogenic, or cytotoxic (Unterberg et al.,
2004). In some cases such as trauma, hypoxic-ischemic encephalopathy, or metabolic
conditions, there can be a mixed pattern of cytotoxic and vasogenic edema (Ho et al.,
2012). Osmotic brain edema develops due to plasma hyposmolality compared to the brain
tissue resulting in fluid accumulation into neurons and glial cells. In contrast, vasogenic
edema develops when there is an increased permeability of capillary endothelial cells due
to a disruption in the blood-brain barrier. The break-down of tight junctions in endothelial
cells allows protein-rich fluid to accumulate in the interstitial space. Traumatic brain
injury, ischemia, and hypoxia can lead to cytotoxic edema and excitotoxicity (Arundine
and Tymianski, 2004). Although cytotoxic edema by itself does not imply net brain
swelling, the formation of cytotoxic edema will deplete the extracellular space of
electrolytes such as Na+ and Cl- and cause a reduction in extracellular water content
(Liang et al., 2007). Thus, cytotoxic edema creates new concentration gradients. During
cytotoxic edema, osmotic imbalances and excess intracellular water are not restored by
adenosine triphosphate (ATP) dependent or passive movement of electrolytes which are
characteristic of physiological cell volume regulation.
Cell volume regulation
Regulation of cellular volume is a vital aspect of cellular homeostasis. Cells are
susceptible to volume changes when there are fluctuations in intracellular or extracellular
osmolarity. During normal physiological conditions, the osmolarity of extracellular fluid
(ECF) in the body including that of brain tissue is maintained relatively constant between
3

285 and 295 mOsm/kg (Wright, 2012). Since ECF osmolality is relatively stable, most
fluctuations in cellular volume are due to changes in intracellular osmolarity (Hoffmann
et al., 2009). Osmotic imbalances can be produced across the plasma cell membrane due
to cellular activity from transport, metabolism, and brain injury (Okada, 2004; Ho et al.,
2012). Cell volume is determined by the cellular content of osmotically active
compounds and by the extracellular osmolality. Thus, as the intracellular content of
osmotically active compounds increases, the extracellular space becomes hypotonic to
the cell interior, and water enters the cell to equalize the osmotic pressure across their
plasma membranes.
Regulatory volume decrease
In response to increased cellular water content, cellular volume can be restored by
the efflux of inorganic and organic osmolytes through a mechanism termed regulatory
volume decrease (RVD). Mechanisms of RVD are not fully understood but involve efflux
of intracellular osmotic content to increase movement of water from the intracellular
compartment. For osmoeffective efflux, net anion efflux must be accompanied by K+
efflux to maintain electroneutrality (Okada et al., 2001). Three different mechanisms are
known to be involved during RVD: K+Cl- co-transporters (KCCs), K+ channels, and Clchannels (Okada, 2004). The organic osmolytes predominantly contributing to RVD in
the brain are amino acids such as aspartate, glutamate, and taurine (Pasantes-Morales,
1996). Mechanisms of RVD are summarized in Figure 1.
Volume-regulated anion channels
Volume-regulated anion channels (VRACs or IClvol) are ubiquitously present in
mammalian cells and are required for the regulation of electrical activity, cell volume,
4

intracellular pH, immunological responses, cell proliferation and differentiation (Duan et
al., 1997). The molecular identity of VRAC remains elusive despite extensive research
and several candidates (Abdullaev et al., 2006; Okada et al., 2009). VRACs are typically
activated during swelling and provide a pathway for efflux of intracellular anions, with
the permeability sequence of SCN->I->NO3->Br->Cl->F->gluconate (Kimelberg et al.,
2004). During cellular swelling, RVD mechanisms involve VRACs to mediate an efflux
of osmolytes but may also show limited activity in non-swollen cells (Mongin and
Kimelberg, 2005). VRACs have a relatively large pore diameter of approximately 1.1 nm
that permits the efflux of small organic osmolytes. VRACs have been shown to release
excitatory amino acids such as aspartate, glutamate, and taurine during increased
extracellular K+, hypoosmotic conditions, oxidative stress, excitotoxic stimulation, and
ischemia (Rutledge et al., 1998; Kreisman and Olson, 2003; Kimelberg, 2004b;
Kimelberg et al., 2004; Abdullaev et al., 2006; Inoue and Okada, 2007; Tucker and
Olson, 2010; Zhang et al., 2011). Inhibition of VRACs has been shown to reduce water
permeability of cellular membranes suggesting that VRACs might also be water
permeable (Nilius, 2004).

5

Figure 1: Mechanisms of regulatory volume decrease. (Left) Cell equalizes the osmotic
pressure through an influx of water. (Right) Cell undergoes regulatory volume decrease
(RVD) via several efflux pathways. Solid lines indicate the cellular membrane prior to
swelling (Left) or RVD (Right). Dotted lines indicate the changes in membrane volume
as a result of swelling or RVD. Abbreviations: K+Cl- Co-transporter (KCC), Cl-/HCO-3
antiporter or anion exchanger (AE), Ca+2 dependent Cl- current ( IClCa), Ca+2 dependent
K+ current (IKCa), volume activated Cl- current (IClvol), volume activated K+ current (IKvol)
From (Hoffmann et al., 2009)
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Figure 1:
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Hippocampus
The hippocampus, a part of the limbic system, is a major component of the
mammalian brain involved in learning and memory. The hippocampus, sometimes
referred to as the hippocampal formation, is a paired structure located in the medial
temporal lobe of the cerebral cortex. In the human brain, the hippocampus appears as a
seahorse-shaped structure that extends into the floor of the lateral ventricle and becomes
continuous with the fornix posterior to the splenium of the corpus callosum. Extensive
research has established microanatomy and circuitry pathways of the hippocampus. Since
different cell types within the hippocampus are organized into layers, the hippocampus
serves as an excellent model for studying neurophysiology.
Cognitive deficits involving the hippocampus are often persistent and severely
debilitating. Individuals with damage to the hippocampus exhibit an inability to form or
retain new memories. Research has connected the hippocampus to multiple diseases
including vascular disease, temporal lobe epilepsy, cognitive aging, post-traumatic stress
disorder, transient global amnesia, schizophrenia, and depressive and anxiety disorders
(Small et al., 2011). Even within the hippocampus, there exists regional differences in
vulnerability to metabolic diseases and stressors that increase with age (Jackson and
Foster, 2009). In addition, due to the physiology of the hippocampus, there is a regional
vulnerability for ischemic injury and cytotoxic edema. Further understanding of the
mechanisms of cell volume regulation in the hippocampus will be vital for addressing the
pathophysiological conditions associated with this structure and will have implications
for damage in the rest of the central nervous system (CNS).
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Structure of the hippocampus
The hippocampus appears as two interlocking C-shaped laminar structures and
typically refers to the dentate gyrus (DG), the hippocampus proper, and the subicular
cortex. Frequently, the extorhinal cortex (EC) is included as part of the hippocampal
formation. The region within the hippocampus proper is subdivided into CA1, CA2 and
CA3 (Amaral and Witter, 1989). In figure 2, regions of the hippocampal formation and
the primiary synaptic connections between these regions are shown in a schematic
drawing. CA1 extends from the dorso-medial subiculum to CA2. CA2 is considered a
small region between CA1 and CA3. CA3 comprises the ventro-medial portion of the
hippocampus. The terminal portion of CA3, as it courses into the dentate hilus, is
sometimes referred to as CA4. Since there is no clear histological features distinguishing
CA3 from CA4, many authors consider CA3 and CA4 regions together as CA3 (DeFelipe
et al., 2007).
Basic synaptic pathways in the hippocampus
The lamellar model considers the hippocampal cortex to be organized into parallel
lamellae forming a tri-synaptic circuit lying within a transverse plane of the
hippocampus (Andersen et al., 1971). Synaptic transmission flows mainly
unidirectionally in the hippocampus proper by three principal pathways: perforant
pathway (PP), mossy fiber pathway, and the Schaffer collateral pathway (SC).
The major input to the hippocampus originates from EC layer II/III neurons
through the PP and directly targets neurons in the CA1, CA2 ,CA3, DG, and subiculum
(Canto et al., 2008). The DG is unique compared to the hippocampus proper because it
has two glutamatergic principal cells: granule cells and hilar mossy cells (Scharfman and
9

Myers, 2012). Hilar mossy cells can either excite or inhibit granule cells, depending on
whether their direct excitatory projections to granule cells or their projections to local
inhibitory interneurons dominate (Jinde et al., 2013). Granule cells, the major principal
cell type in the DG, are quiescent and send projections exclusively to the CA3 region via
mossy fibers (Krautwald and Angenstein, 2012). In contrast, mossy cells exhibit
spontaneous activity (Duffy et al., 2013) and receive back-projections from CA3
pyramidal neurons (Jinde et al., 2013). The CA3 pyramidal neurons send axons to CA1
pyramidal cells through the SC and to the CA1 cells in the contralateral hippocampus.
The CA1 and the subiculum receive direct input from EC layer III neurons through the
temporoammonic pathway (TA). CA1 pyramidal cells mainly target the adjacent
subiculum and the entorhinal cortex in addition to various cortical areas (Cenquizca and
Swanson, 2007). The CA1 and subiculum are the major output structures of the
hippocampus given that their projections terminate in a variety of subcortical and cortical
areas including the entorhinal cortex (Witter, 2006).
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Figure 2: Anatomy of the rodent hippocampus and neural network.
a) A transverse slice from the rodent brain is enlarged to depict the regions of the
hippocampus and basic circuitry. b) Schematic of the excitatory trisynaptic pathway is
depicted by solid black arrows. Abbreviations: EC, entorhinal cortex; DG, dentate gyrus;
PP, perforant pathway; LPP, lateral perforant pathway; MPP, medial perforant pathway;
CA, Cornu Ammonis; TA, temporoammonic pathway. From (Deng et al., 2010)
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Figure 2:
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Layers of the hippocampus
The axons, cell bodies, and dendrites of pyramidal cells, the principal excitatory
neurons of the hippocampus, are arranged through seven well-defined layers: alveus,
stratum oriens, stratum pyramidale, stratum lucidum, stratum radiatum, stratum
lacunosum, and stratum moleculare. Hippocampal pyramidal neurons, frequently
regarded as a homogeneous cell population, (Szilagyi et al., 2011) form the stratum
pyramidale with the cell bodies of various interneurons.
In the rodent, CA1 pyramidal neurons form a compact layer consisting of 5 to 8
superimposed rows of pyramidal neurons (Mizuseki et al., 2012). The ventricular portion,
or deepest layer of the hippocampus, known as the alveus, consists of the myelinated
axons from pyramidal cells (DeFelipe et al., 2007). Axons in the alveus bifurcate with
branches extending rostrally through the fornix system and caudally toward the
retrohippocampal region of the hippocampus where they contribute to the
intrahippocampal circuit (Cenquizca and Swanson, 2007).
Stratum oriens (str. oriens) is superficial to the alveus consisting mainly of the
basal dendrites from the pyramidal cells and several classes of interneurons. Oriens
lacunosum-moleculare (O-LM) cells, a major class of GABAergic interneurons, have
their horizontal dendrites and somata in the str. oriens (Szilagyi et al., 2011) and inhibit
the distal apical dendrites of pyramidal cells (Leao et al., 2012).
The stratum lucidum (str. luc.) is only present in the CA3 region and contains
mossy fibers from dentate gyrus granule cells. The stratum radiatum (str. rad.) contains
apical dendrites from pyramidal cells and several types of interneurons. Interesting,
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astrocytic processes in stratum radiatum of area CA1 represent only ∼5% of the neuropil
contrasting with ∼27% in cerebellar cortex (Ventura and Harris, 1999).
The SC fibers, which are the axons from the CA3 pyramidal neurons innervating
predominantly dendritic spines of CA1 pyramidal cells, run through the str. rad. and the
stratum lacunosum (str. lac.). Interneuron cell bodies of the Schaffer collateral associated
cells course along the SC fibers in the str. rad. up to the border of the str. lac. (Szilagyi et
al., 2011). The str. lac. also contains PP fibers from the superficial layers of EC. Due to
the small size of the str. lac., it is often grouped together with stratum moleculare (str.
mol.) into a single stratum called stratum lacunosum-moleculare (str.lac-mol) which has
an approximate thickness of 150 µm (Kajiwara et al., 2008). The str.lac-mol contains
axons of the TA pathway from layer III EC neurons which synapse with the distal apical
dendrites of CA1 pyramidal cells (van Groen et al., 2002; Cai et al., 2013). Str. mol. is
the most superficial stratum in the hippocampus and consists of PP fibers which form
synapses onto the distal portion of the apical dendrites of CA3 pyramidal cells.
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Figure 3: Labeled regions and layers of rodent hippocampus from a 3H-thymidine
autoradiogram of a rodent hippocampus slice. The picture shows stratum lacunosum and
stratum moleculare together as stratum lacunosum-moleculare. CA2 region is not labeled.
Taken from the website of braindevelopmentmaps.org (Altman and Bayer, 2012)
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Figure 3:
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Schaffer collateral synaptic physiology
Schaffer collateral pathway action potentials
The SC pathway was utilized in these studies to elicit monosynaptic stimulation
of pyramidal cells in the CA1 region. Synaptic transmission of the SC pathway is
controlled by the ionic gradient across the axolemma that supports action potentials
which travel towards the nerve terminal. At rest, the cytoplasm of neurons has a low
concentration of Na+ and Cl- and a high concentration of K+ relative to the extracellular
fluid. In adult pyramidal neurons, intracellular Cl- is estimated to be 4 mM (Tyzio et al.,
2008). Several specialized leak channels and the Na+/K+ ATPase, which pumps 3 Na+ out
of the cell in exchange for 2 K+ into the cell, maintain this concentration gradient of ions.
Due to the constant pumping activity of the Na+/K+ ATPase, cells maintain a high
intracellular K+ concentration.
During synaptic activity of the SC pathway, the CA3 pyramidal neuron membrane
potential first becomes depolarized due to voltage-gated Na+ channels that mediate an
influx of Na+ ions into the cell body. Once the membrane potential reaches a threshold
voltage, an action potential can be elicited. The large depolarization peak of the action
potential causes voltage-gated Na+ channels to inactivate such that Na+ influx stops
before the cells reach the equilibrium potential for Na+. Then a rapid efflux of K+ ions
through voltage-gated K+ channels causes the membrane potential to repolarize towards
resting membrane potential. The membrane potential continues towards the equilibrium
of K+ ions. An afterhyperpolarization of the membrane occurs where the membrane
potential is transiently more negative than the resting membrane due to slow inactivation
of voltage-gated K+ channels. Once the voltage-gated K+ channels close, the resting
17

membrane potential is reestablished through the specialized leak channels and Na+/K+
ATPase.
The action potential of the CA3 pyramidal neuron propagates towards the nerve
terminal through an axon in the str. rad. and str. lac. When action potentials arrive at the
presynaptic nerve terminal, Ca2+ influx is mediated by voltage-gated Ca 2+ channels.
Presynaptic Ca+2 influxes contribute to approximately 75% of stimulus-induced
intracellular Ca+2 transients in the stratum radiatum (Liotta et al., 2012). Each presynaptic
nerve terminal contains hundreds of synaptic vesicles that are filled with
neurotransmitters (Sudhof and Rizo, 2011). Various specialized proteins assemble to
release synaptic vesicles in the presence of elevated intracellular Ca+2. The synaptic
vesicles fuse with the presynaptic membrane and release neurotransmitters into the
specialized extracellular space of the synaptic cleft to bind on postsynaptic membrane
receptors of the CA1 pyramidal cells. Postsynaptic activation and generated action
potentials contribute to approximately 50% of the stimulus-induced ion fluxes in the
stratum radiatum during SC activity (Liotta et al., 2012).
Glutamatergic synapse
Glutamate, a small amino acid, is the primary excitatory neurotransmitter in the
CNS including the hippocampal pyramidal cells. When in excess, glutamate is considered
a powerful neurotoxin. Although glutamate serves multiple roles in the central nervous
system, this review will concentrate on glutamate as a neurotransmitter in the Schaffer
Collateral pathway of the hippocampus and the ionotropic glutamate receptors involved
in glutamatergic signaling. In the nerve terminal of pyramidal cells, glutamate is stored in
small spherical synaptic vesicles for eventual release as a neurotransmitter. Upon
18

stimulation of the nerve terminal, synaptic vesicles fuse with the presynaptic cell
membrane, releasing their content into the synaptic cleft. Glutamate diffuses across the
synaptic cleft between the nerve terminal and dendritic spine of the CA1 pyramidal cell.
Once in the synaptic cleft, glutamate binds to glutamate-specific receptors (GluRs)
present on neurons and glia. Activation of GluRs alters membrane permeability primarily
to cations and depolarizes the post-synaptic membrane of the CA1 pyramidal cell. The
process is terminated as glutamate is transported via specific glutamate transporters
(GluTs) back into the pre-synaptic neuron and into surrounding glial cells. Glutamate
returning into the pre-synaptic neuron is packaged directly into synaptic vesicles by
vesicular glutamate transporters (VGluTs). However, glutamate transported into glial
cells rapidly enters the glutamate-glutamine cycle. Glial cells convert the accumulated
glutamate to glutamine for transfer into neurons. Then glutamine is converted back to
glutamate and re-packaged into vesicles. Glutamate re-uptake into glial cells is vital for
maintaining a low extracellular concentration of this excitatory neurotransmitter, thus
preventing excessive glutamate excitation and excitotoxicity.
Glutamate receptors
Glutamate triggers rapid changes in membrane conductance through activation of
glutamate receptors. There are two general classes of GluRs present on neurons and glia:
ionotropic glutamate receptors (iGluRs) and metabotropic glutamate receptors (mGluRs).
iGluRs are glutamate-gated cation channels that have traditionally been classified into
three subtypes based upon pharmacological and electrophysiological data: NMDA (Nmethyl-D-aspartate) receptors (NMDARs), AMPA (α-amino-3-hydroxy-5-methyl-4isoxazolepropionic acid) receptors (AMPARs) , and kainate receptors (KARs)
19

(Dingledine et al., 1999). The mGluRs are G-protein coupled receptors that exert a
variety of modulatory effects through their recruitment of second messenger systems
(Pinheiro and Mulle, 2008). In this study, the focus on glutamate receptors will be limited
to the ionotropic glutamate receptors and their roles in the glutamatergic synapse in the
hippocampus.
AMPARs
The AMPARs consist of four subunits, GluA1-GluA4, (Hollmann and
Heinemann, 1994; Collingridge et al., 2009) that assemble into a tetrameric complex to
form a functional ion channel that is permeable to Na+ and K+ ions (Mano and Teichberg,
1998). Although most AMPARs are impermeable to Ca+2, recent research has revealed
the presence of calcium-permeable AMPARs (CP-AMPARs) in hippocampal neurons
and astrocytes (Sans et al., 2003; Verkhratsky and Kirchhoff, 2007). Certain types of
neural activity such as paired-pulse stimulation reveal CP-AMPARs present at
perisynaptic sites of the CA1 synapses from Schaffer collaterals (He et al., 2009). But
under physiological conditions, CA1 pyramidal cells abundantly express GluA2containing Ca2+ -impermeable AMPARs (Liu and Zukin, 2007). In neurons, AMPARs
are located predominantly on the post-synaptic membrane but are also found at extrasynaptic sites and occasionally on the pre-synaptic membranes (Sprengel, 2006).
Fluorescent in situ hybridization and immunocytochemistry studies have localized
AMPAR subunits in the somata and dendrites of CA3 and CA1 pyramidal cells,
especially in the apical dendrites of pyramidal cells (Cox and Racca, 2013). Glutamate
activated neuronal AMPARs allow an influx of cations which depolarize the membrane
and generate excitatory postsynaptic potentials (EPSPs). Since AMPAR activation
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requires only the presence of glutamate, AMPARs can mediate fast excitatory synaptic
transmission in the hippocampus (Lau and Tymianski, 2010).
KARs
The KAR is a tetrameric iGluR that is composed of diverse combinations of five
subunit proteins: GluK1, GluK2, GluK3, GluK4 and GluK5 (Collingridge et al., 2009;
Copits and Swanson, 2012). Until recently, KARs were often referred together with
AMPARs because of similar biophysical properties and the limited ability to selectively
target KARs pharmacologically (Jane et al., 2009; Copits and Swanson, 2012). KARs are
glutamate-gated channels that are permeable to cations and display rapid activation and
desensitization characteristics (Pinheiro and Mulle, 2006). KARs are ubiquitously
distributed throughout the brain and act predominantly as modulators of synaptic
transmission and neuronal excitability (Contractor et al., 2011). Numerous studies have
demonstrated the presence of functional KARs in various neuronal populations on
presynaptic and postsynaptic membranes (Pinheiro and Mulle, 2006). In the
hippocampus, KARs have been shown to modulate inhibitory synaptic transmission in
the CA1 region and require high-frequency stimulation in CA3 pyramidal neurons
(Swanson and Heinemann, 1998). KARs are most likely localized at presynaptic
GABAergic synapses to modulate GABA release from interneurons (Rodriguez-Moreno
et al., 1997). Glial KARs also have been localized diffusely with AMPARs on the somata
of oligodendrocytes (Salter and Fern, 2005).
NMDARs
NMDARs are heteromeric complexes composed of different subunits from a
collection of three subtypes: GluN1, GluN2, and GluN3 (Paoletti and Neyton, 2007;
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Collingridge et al., 2009). NMDARs have binding sites for glutamate, polyamines, Mg+2,
and glycine (Wollmuth et al., 1998b, a; Ghasemi and Dehpour, 2011). Similar to the
manner in which Mg2+ interacts with residues that form the narrow constriction in the
NMDA channel pore, numerous polyamines have been identified that modulate
NMDARs (Berger et al., 2013). The activation of NMDARs requires binding of
glutamate in addition to glycine or D-serine. In neurons at resting membrane potential,
NMDARs which bind glutamate remain in a low conductance state because the channel
pore is blocked by Mg2+ ions. Under these basal conditions, an EPSP resulting from a
glutamatergic synapse will be mediated entirely by AMPA receptors. However,
membrane depolarization due to AMPAR activation can expel the Mg2+ from the NMDA
channel. With a depolarized membrane and a co-agonist (glycine or d-serine ), the
glutamatergic impulses can activate NMDARs to allow the influx of monovalent cations,
including Na+ and divalent cations, most notably Ca2+ (Kalia et al., 2008). Ca+2 ions then
can act as an important second messenger to activate intracellular signaling cascades.
NMDARs have been found to be co-localized with AMPARs in the postsynaptic density
of the vast majority of glutamatergic synapses in the brain (Pinheiro and Mulle, 2006).
Once considered exclusively neuronal, NMDARs have now been demonstrated to
be expressed in glial cells. In astrocytes and oligodendrocytes, NMDARs are expressed
on the distal processes, a distribution which is unlike other iGluRs (Conti et al., 1996;
Salter and Fern, 2005). Glial NMDARs have been found to be approximately 25 times
more sensitive to glutamate compared to AMPA receptors (Lalo et al., 2006). Together,
the location and sensitivity to glutamate suggest that NMDRs might contribute to
monitoring glutamate levels in the extracellular space. Glial NMDARs have been found
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to be either completely insensitive or weakly sensitive to extracellular Mg2+ (Lalo et al.,
2006). As a result, glial NMDARs are functional at resting membrane potentials and
allow the influx of Na+ and Ca2+ ions into the glia. Although the role for NMDARs in
generating astroglial Ca2+ signals is generally neglected, synaptic stimulation of
NMDARs has been shown to contribute up to 50% of intracellular Ca2+ in cortical
astrocytes (Palygin et al., 2010; Lalo et al., 2011). As in neurons, increased intracellular
Ca+2 ions can act as an important second messenger to activate specialized proteins and
intracellular signaling cascades. In cultured astrocytes, Ca+2 influx is required to obtain
glutamate-induced volume increases (Hansson et al., 1994).
Glutamate Transporters (GluTs)
GluTs, known as excitatory amino acid transporters (EAATs), are abundant in
neuronal and glial membranes and bind glutamate rapidly. The exact stoichiometry of
GluT among the different isoforms of GluTs is still debated but it is considered that the
uptake of 1 glutamate molecule is thermodynamically coupled with the influx of 3 Na+, 1
H+, and the efflux of 1 K+ (Lopez-Bayghen and Ortega, 2011; Stone et al., 2012). Thus,
GluTs use secondary active transport to maintain a 106-fold glutamate concentration
gradient across the cell membrane (Gameiro et al., 2011). During ATP reduction and
altered osmotic states, glutamate transport can be reversed (Takahashi et al., 1997).
The rapid kinetics of GluT serves several functions at the glutamatergic synapse. The
uptake of glutamate preserves the electrical signal by maintaining a low non-toxic
extracellular glutamate concentration, typically less than 1 µM (Simard and Nedergaard,
2004). GluTs can modulate the time and extent of glutamate receptor activation. Uptake
of glutamate also limits the spillover of glutamate into neighboring synapses and
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extrasynaptic areas. Because of the rapid accumulation of glutamate from the
extracellular space by GluT, this process is the primary mechanism for the inactivation of
synaptically released glutamate (Rothstein et al., 1996). For astrocytes, glutamate uptake
can be mediated either by Na+-independent or Na+-dependent mechanisms. The Na+independent uptake represents only a small proportion of total astrocyte glutamate uptake
and is typically done via chloride dependent glutamate/cysteine antiporters (Anderson
and Swanson, 2000). Na+-dependent glutamate uptake governs the majority of Na+ influx
into astrocytes in situ (Langer and Rose, 2009) GluTs in astrocytes are considered the
most important for maintaining normal glutamate concentrations and providing a
pathway for glutamate metabolism. Astrocytic GLuTs clear approximately 80% of
glutamate released during synaptic transmission (Verkhratsky and Kirchhoff, 2007).
The task of glutamate clearance in the CNS is spread among six different GluTs, encoded
by five distinct genes: EAAT1, EAAT2, EAAT3, EAAT4, and EAAT5 (Huang and
Bergles, 2004). The subtypes EAAT1 and EAAT2 are mostly expressed in glial cells,
whereas EAATs 3–5 are neuronal (Gameiro et al., 2011). In the hippocampus, EAAT1,
EAAT2, and EAAT3 (Stone et al., 2012) are expressed and of those EAAT2 is
considered the most prominent (Danbolt, 2001). The rat homologs of EAAT1, EAAT2,
and EAAT3 are GLAST, GLT-1, and EAAC1 respectively. In the hippocampus, GLAST
and GLT-1 are expressed as glial glutamate transporters in astrocytes, while EAAC1 is
expressed as a neuronal glutamate transporter (Tsukada et al., 2005). Glial processes
contain high levels of GLT as well as GLAST (Lehre and Danbolt, 1998). The
concentration of GluTs in the stratum radiatum of hippocampus CA1 is approximately
15,000 per µm3 tissue with GLT concentration as high as 12,000 per µm3 (Lehre and
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Danbolt, 1998). GLT and GLAST clear the majority of extracellular glutamate while
EAAC1 is estimated to account for the remaining 40% of glutamate uptake (Rothstein et
al., 1996).
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Figure: 4 Summary of glutamatergic synaptic activity. The illustration shows the basic
aspects of the Schaffer collateral glutamatergic synapse. Glutamate (Glu) from the
presynaptic neuron (purple) is released into the extracellular space. Glutamate then can
bind to NMDARs, AMPARs, KARs and mGluRs. (Note that, although not shown here,
iGluRs also are located on presynaptic neuronal and on glial membranes). Glutamate is
cleared from the extracellular space by EAATs present in astrocytes (blue) and neurons
(purple). Glutamate is recycled and packaged into synaptic vesicles via VGluTs. From
(Swanson et al., 2005)
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Figure 4:
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Glutamate-glutamine cycle
The uptake of glutamate by glial cells serves as the major pathway by which
glutamate is recycled back to neuronal synaptic boutons. Glutamate released during
neurotransmission is taken up primarily by neighboring astrocytes through GluTs.
Glutamate then is amidated to glutamine by the ATP-dependent, glia-specific enzyme
glutamine synthetase (Danbolt, 1994; Albrecht et al., 2010) . Glutamine also can be
converted into alpha-ketoglutarate by glutamate dehydrogenase or aspartate
aminotransferase for subsequent oxidative metabolism in the TCA cycle (Stobart and
Anderson, 2013). Efflux of glutamine from astrocytes into the extracellular fluid occurs
via system N transporters while system A transporters (SAT) actively transport glutamine
into neurons (Chaudhry et al., 2002). Imported glutamine is converted back into
glutamate in the neuron through deamination by mitochondrial phosphate activated
glutaminase (Kvamme et al., 2000). Neuronal glutamate is transported into synaptic
vesicles via vesicular glutamate transporters (VGluTs) which are located in the
membrane of synaptic vesicles. VGluTs are supplied with energy through a Mg+2dependent ATPase in the vesicular membrane which pumps H+ ions into the vesicles
(Danbolt, 2001). Without Mg+2 and ATP to fuel the proton pump, glutamate leaks out of
the vesicles down the concentration gradient by reversal of VGluT (Danbolt, 1994).
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Figure 5: Glutamate-glutamine cycle. This basic schematic of the glutamate-glutamine
cycle between astrocytes and neurons is shown here. This schematic does not show
system N transporters, system A transporters, and vesicular glutamate transports.
Abbreviates: glutamate (Glu), excitatory amino acid transports (EAATs), glutamine
(Gln), glutamine synthase (GS), alpha-ketoglutarate (α-KG), glutamate dehydrogenase
(GDH), aspartate aminotransferase (AAT), phosphate-activated glutaminase (PAG),
tricarboxylic acid cycle (TCA). From (Stobart and Anderson, 2013).
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Figure 5:
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Electric-activity dependent volume changes
Potassium spatial buffering of action potentials
Regulation of extracellular K+ in the brain is essential for neuronal excitability
and is recognized as a major function of astrocytes (Bay and Butt, 2012). There are
narrow ranges for K+ fluctuations and yet these fluctuations are a necessary consequence
of synaptic transmission (Walz and Hertz, 1983). An elevated extracellular K+ may
induce uncontrolled hyperexcitability and abnormal synchronization of neurons. Seizure
activity in vivo is characterized by elevations in extracellular K+ from 3 mM to a ceiling
level of 10–12 mM (Seifert et al., 2006). Conduction properties of CA1 afferents are
sensitive to elevations in extracellular K+ (Poolos et al., 1987).
During synaptic transmission, neural depolarization is halted by an efflux of K+
through voltage-gated K+ channels. The concentration of extracellular K+ increases in the
compact extracellular space surrounding neurons and glia following activity. Gap
junctions in astrocytes constitute a syncytium for ion movement (Witte et al., 2001) and
are thought to facilitate spatial buffering of extracellular K+ during synaptic activity by
redistributing K+ to places with low extracellular K+. However, recently, transgenic mice
with gap junction deficient astrocytes revealed a large capacity for K+ redistribution
suggesting that gap junction-dependent processes only partially account for K+ buffering
in the hippocampus (Wallraff et al., 2006). At perivascular endfeet, K+ efflux is an
effective vasodilator which serves to satisfy enhanced glucose and oxygen demand
during neuronal activity (Filosa et al., 2006). Gap junctions also interconnect
perivascular glial endfeet which also contain various K+ channels, aquaporin channels
(AQP), and purinergic receptors (Simard et al., 2003; Assentoft et al., 2013; Stobart and
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Anderson, 2013). In the hippocampus, AQP4 is expressed in CA1, where it may
facilitate the rapid water fluxes that are required for maintaining K+ homeostasis during
electrical activity (Papadopoulos and Verkman, 2013). Interestingly, AQP4 expression is
strongest in the CA1 str. lac-mol suggesting this sublayer is important for astrocytic K+
and water regulation.
Studies using patch-clamp technique demonstrated expression of voltage-gated K+
channels, Ca+2 activated K+ channels, and inward rectifying potassium channels (Kir) in
glial cells. However, physiological properties of Kir channels suggest that this channel
is responsible for the majority of K+ clearance from the extracellular space (Horio, 2001).
Recent work suggests astrocytes exhibit co-localization of Kir4.1 with AQP4 (MacAulay
and Zeuthen, 2010). Thus, volume regulation in glia may require cooperation of AQP4
and Kir4.1 activities (Seifert et al., 2006). Kir and Na+/K+ ATPase have been found
important for K+ clearance during synaptic activity (Bay and Butt, 2012). However,
recent data from other studies have stressed the importance of brain Na+/K+ ATPase
rather than glial channel-mediated removal for clearing extracellular K+ (Meeks and
Mennerick, 2007). Finally, during stimulation, astrocytes experience an influx of Ca+2
which has been found to stimulate Na+/K+ ATPase thus decreasing extracellular K+
(Wang et al., 2012). From these studies, Na+/K+ ATPase is thought to be responsible for
K+ clearance during stimulation while glial Kir4.1 is primarily responsible for
maintaining steady-state extracellular K+ by releasing K+ back into the extracellular space
to off-set active K+ uptake via Na+/K+ ATPase.
Although glial swelling during neuronal activity is well known, the exact
mechanisms underlying this swelling are unclear (MacAulay and Zeuthen, 2010). It is
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thought that astrocytes experience a water influx to balance the osmotic pressure due to
the increase in astrocytic K+, leading to swelling of the astrocyte and a decrease in the
extracellular space.
Glutamate-mediated cell volume regulation
In the glutamatergic synapse, glutamate has been shown to mediate volume
regulation through different pathways. Several studies have shown that glutamatergicpurinergic signaling contributes to osmotic volume regulation of retinal glial cells (Wurm
et al., 2008; Wurm et al., 2010; Linnertz et al., 2011). A purinergic signaling cascade
includes the release of ATP, activation of purinergic receptors on glia, and subsequent
efflux of Cl- and K+ accompanied by water efflux as part of the regulatory volume
decrease mechanism (Darby et al., 2003; Uckermann et al., 2006). It is thought that
glutamate activation of mGluRs causes a release of ATP from glial cells to activate
purinergic receptors (Kalisch et al., 2006; Wurm et al., 2008). In addition, glutamatergicpurinergic signaling has been found to evoke taurine efflux in the substantia nigra in
response to hypoosmolarity (Morales et al., 2007; Morales et al., 2009). These findings
suggest that glutamatergic-purinergic signaling also may apply to volume regulation
during synaptic activity.
Glutamate activation of all three iGluRs has been found to significantly enhance
taurine release (Oja and Saransaari, 2013b) while activation of mGluRs was found to
have a minor role in the regulation of taurine release (Oja and Saransaari, 2013a). During
oxidative stress, NMDAR activation was found to be associated with volume regulation
in the hippocampus (Tucker and Olson, 2010). Interesting, activation of AMPARs in the
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substantia nigra induced a dose-response increase of taurine while NMDARs showed no
response (Garcia Dopico et al., 2004).
Despite the years of research, the mechanisms underlying glutamate-mediated
volume regulation in neurons and glial cells during synaptic transmission remain largely
unclear. In this present study, volume regulation of neurons and glia in the glutamatergic
synapse will be examined. These experiments will elucidate the specific role of glutamate
in cell swelling and volume regulation during stimulation.

Model of volume regulation during synaptic activity
Figure 6 illustrates the current understanding of volume regulation during
stimulation. When an action potential reaches the glutamatergic pre-synaptic terminal of
a nerve cell, it causes an elevation in intracellular Ca+2 due to the opening of voltagedependent Ca+2 channels. This rise in calcium ultimately triggers the fusion of glutamate
containing synaptic vesicles with the cell membrane. The release of glutamate diffuses
across the narrow region of the synaptic cleft between the presynaptic membrane of the
axon and the postsynaptic membrane of the target dendrite.
Glutamate binds to iGluRs on neurons and glial cells causing an influx of cations.
Additionally, astrocytes rapidly clear excess K+ and glutamate from the extracellular
space. The intracellular water influx which results from these ion movements into cells
relieves osmotic pressure gradients and decreases the volume of the extracellular space.
The cells which are swollen then can undergo RVD via several specialized channels
including VRACs to release ions and organic osmolytes into the extracellular space.
Several studies have demonstrated that glutamate-mediated volume regulation
mechanisms involving iGluRs facilitate RVD.
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While each of these mechanisms has been studied in isolated cell systems, there
has been no attempt to examine these processes in the context of physiological neuronal
activity in situ. Thus, the role of synaptic activity, glutamate, and VRACs in stimulationinduced swelling and recovery is unclear. In this present study I will examine the effects
of stimulation, iGluR inhibition, GluT inhibition, and VRAC inhibition to elucidate the
specific role of glutamate in cell volume regulation during stimulation-induced cellular
swelling.
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Figure 6: Mechanisms underlying stimulation-induced volume changes (A)
Representation of an astrocyte (purple) and myelinated neurons (blue myelin, yellow
neuron). The active synapse is highlighted in red. (B) The active synapse is enlarged to
illustrate astrocytic swelling in response to synaptic activity. (Left) Inactive glutamatergic
synapse and astrocytic VRACs are inactive. (Middle) During synaptic activity, K+ and
glutamate are released into the extracellular space. Glutamate binds to GluRs causing
neurons and glia to experience an influx of cations (not shown). Neuronal swelling is not
shown due to cations is not shown. Astrocytes experience an influx glutamate and K+ via
glutamate transports and K+ channels respectively. A water influx via aquaporins relieves
the osmotic pressure in astrocytes resulting in an increased cellular volume and decreased
extracellular space. (Right) Osmotic swelling triggers VRACs to mediate the efflux of
anions and excitatory amino acids. From (Mulligan and MacVicar, 2006). Reprinted with
permission from AAAS.
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Figure 6:
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III: OBJECTIVE & SPECIFIC AIMS
The complex and dynamic interactions that occur at the synaptic level between
neurons and glia pose a challenge for understanding volume regulation during functional
brain activity. The mechanisms and osmolytes involved in cellular volume regulation
during synaptic activity remain uncertain. This research is intended to characterize
stimulation–induced volume changes in the hippocampus. To accomplish this task, the
interactions between neurons and glia were studied with several specific aims.

Specific aims
Examine the effects of stimulation frequency on cell volume.
The first goal of this study was to identify and characterize the effects of different
stimulation frequencies on cell volume. This was accomplished using several different
frequencies to orthodromically stimulate the Schaffer collateral pathway while measuring
cellular volume simultaneously. A frequency with a measurable change in IOS that
offered the most consistent results was selected for the remainder of this project.
Investigate the effects of synaptic block on cell volume.
The second goal of this study was to determine if pre-synaptic activity contributed to
stimulation-induced swelling. The synaptic transmission was blocked with
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a pharmacological agent and field potential records were used to confirm that synaptic
transmission was blocked.
Distinguish the effects of iGluR inhibition on cell volume.
The third goal of this study was to determine the involvement of ionotropic glutamate
receptors in volume regulation during stimulation. Pharmacological agents were used
during stimulation to inhibit iGluRs present on neurons and glia while observing the
changes in cellular volume. The effects of AMPA inhibition and NMDA inhibition were
studied separately, as well as together, to observe the effects of total iGluR inhibition.
The field potential recordings were used to confirm effectiveness of AMPA inhibition by
the absences of excitatory post-synaptic potentials. Field potentials during NMDA
inhibition were used to confirm that excitatory post-synaptic potentials remained because
neurons were being depolarized by the AMPARs. During total iGluR inhibition, the field
potentials were used to confirm that excitatory post-synaptic potentials were blocked due
to AMPA inhibition.
Identify the effects of glutamate reuptake inhibition on cell volume.
At the excitatory glutamatergic synapse of the Schaffer collateral pathway, the effects
of glutamate reuptake were investigated by the application of a pharmacological agent to
block GluTs present on neurons and glia. The field potential recordings were used to
confirm that glutamate was accumulating within the synaptic cleft resulting in increased
excitability. The cellular volume changes were observed during stimulation with the
inhibition of GluTs.
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Characterize the effects of VRAC inhibition on cell volume.
The final goal of this study was to determine the involvement of VRAC during
stimulation-induced swelling. Given that VRACs activate during cell swelling, the
involvement of VRACs was expected to be evident. The inhibition of VRACs was
achieved with several different drugs to characterize the changes in IOS.

Significance
These studies will further our understanding of volume regulation that occurs
during functional brain activity. This information will provide insight into the osmolytes
that are contributing to stimulation-induced swelling and the recovery process of cellular
volume. Together, the understanding of volume regulation and the osmolytes involved in
volume regulation during physiological conditions will advance treatment protocols for
pathophysiological conditions that potentially could lead to brain edema.
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IV. MATERIALS AND METHODS
Chemicals
NaCl, dimethyl sulfoxide (DMSO), 2-aminoethanesulfonic acid (taurine), 5-nitro2-(3-phenylpropylamino)benzoic acid (NPPB), 6-cyano-7-nitroquinoxaline-2,3-dione
(CNQX), (+)-MK-801 hydrogen maleate (MK801) were obtained from Sigma-Aldrich
(St. Louis, MO). MgSO4, NaHCO3, and KCl were procured from Fisher Scientific
(Fairlawn, NJ). CaCl2∙2H20, NaH2PO4∙H20 and D-glucose (dextrose) were from JT Baker
(Phillipsburg, NJ); NaH2PO4∙H20 was also obtained from VWR (Westchester, PA); 4-[(2butyl-6,7-dichloro-2-cyclopen-tyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy]butanoic acid
(DCPIB) and (3S)-3-[[3-[[4-(trifluoromethyl)ben-zoyl]amino]phenyl]methoxy]-Laspartic acid (TFB-TBOA) were acquired from Tocris Biosciences (Ellisville, MO); 2-[3(trifluoromethyl)anilino]nicot-inic acid (niflumic acid) was procured from ICN
Biomedicals (Aurora, OH); 95% ethyl alcohol (ethanol) was from AAPER (Shelbyville,
KY).

Animals
All experiments performed were approved by the Laboratory Animal Care and
Use Committee (LACUC) at Wright State University. Fifty-five adult Sprague-Dawley
rats of either sex 237±83g (mean ± standard deviation) were housed in a controlled
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environment at the Laboratory Animal Care facility at Wright State University. The room
temperature was maintained at 74˚F. Rats were housed in full-spectrum fluorescent lights
on a 12:12 light:dark cycle. All rats were provided standard tap water and standard feed
ofTeklad 8640 Rodent diet (Harlan Laboratories, Madison, WI) ad libitum. The contact
bedding used for all experiments was either corn cob (0.6 cm), (The Andersons Inc.,
Maumee, OH) or aspen chip (Sani Chip, Harlan Laboratories). Rats were transported
individually to the laboratory in cages with bedding, food and water. Cages were
designed to minimize potential exposure of the animals to disease and personnel to
animal allergens on the day of the experiments.

Slice preparation
Once the animal arrived to the laboratory, its weight was recorded and it was
anaesthetized for perfusion. Transverse 400 µm thick hippocampus slices were prepared
using methods similar to those previously described (Tucker and Olson, 2010; Lein et al.,
2011). Animals were anaesthetized to apnea using isoflurane and then perfused via the
left cardiac ventricle with ice-cold isotonic artificial cerebrospinal fluid (aCSF) that had
been equilibrated with 95% O2 plus 5% CO2. Isotonic aCSF consisted of (in mM): 124
NaCl, 3.5 KCl, 2 CaCl2, 1 MgSO4, 1 Na2HPO4, 26 Na2HCO3, and 10 glucose. Animals
then were decapitated and the brain placed into a frozen slurry of aCSF for at least 5 min.
Transverse hippocampal tissue slices then were prepared from the middle third of each
hippocampus. Figure 7 illustrates the relative position of such a transverse slice within
the rat brain (Amaral and Witter, 1989). Slices were cut in a plane that preserved Schaffer
collateral connections (Teyler, 1980) and then were transferred to a preincubation
chamber where they remained for at least 60 min at room temperature in aCSF
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equilibrated with 95% O2 plus 5% CO2. For most slices, 1 mM taurine was added to the
aCSF to maintain normal tissue taurine content (Kreisman and Olson, 2003). After the
slice preparation and a 60 min preincubation period, slices were transferred individually
to the recording stage of a Haas-type interface chamber and perfused with aCSF
equilibrated with 95% O2 plus 5% CO2 at 35°C. For slices exposed to 1 mM taurine
during room temperature incubation, the same taurine concentration was present during
the first 30 min of perfusion on the recording stage.
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Figure 7: Lateral view of hippocampal formation in the rodent brain. The parietal and
temporal neo-cortex are removed to expose the position of the hippocampal formation.
The transverse axis (Trans) is shown perpendicular to the long septotemporal axis of the
hippocampus. A transverse slice is depicted from the middle of the left hippocampus and
enlarged at the top left to show the intrinsic synaptic connections. Abbreviations: CA1,
Cornu Ammonis 1;CA3, Cornu Ammonis 3;DG, dentate gyrus; mf, mossy fibers; pp,
perforant path; S, subiculum; Se, septal; sc, Schaffer collaterals; T, temporal.
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Electrophysiology
Electrical stimulation
All experiments were conducted inside a Faraday cage to prevent electrostatic and
electromagnetic inference. pClamp 6 software (Axon Instruments, Union City, CA) was
used for stimulation control in combination with a single channel stimulator (S-900,
Dagan Corporation, Minneapolis, MN) and stimulus isolation unit (S-910, Dagan
Corporation, Minneapolis, MN). A stimulation pulse of 200 µsec length was delivered at
30 sec intervals to a bipolar electrode made of 178 µm diameter Teflon-coated stainless
steel wires. The stimulating electrodes were placed in the stratum radiatum of the CA3
region to orthodromically stimulate the Schaffer collateral pathway (Figure 8). These
electrodes were placed prior to positioning the glass recording electrode to prevent
damage to the recording electrode by movement of the slice. Low frequency stimulation,
considered a pulse frequency rate of once every 30 sec, was delivered to slice prior to
high frequency stimulation trains. During high frequency stimulation, slices received a
train of pulses at 1, 3, 5, or 10 Hz for 5 minutes. After the stimulation train, low
frequency stimulation resumed. If slices were given more than one high frequency
stimulation train, the trains were separated by 5 min. pClamp 6 software was used for
data acquisition and analysis.
Field potential recording
Population field potentials from pyramidal neurons were recorded with a glass
microelectrode (WPI inc, Sarasota, FL) filled with aCSF (~50 MΩ) and positioned in
either the pyramidal cell layer or stratum radiatum of CA1 (Figure 2). Voltages were
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measured with a high input impedance dual differential electrometer (FD223, WPI Inc,
Sarasota, FL). The responses to stimulation were filtered using a 2 pole 5 kHz low-pass
and amplified ×10 during data acquisition. The resulting waveform was displayed on an
oscilloscope and digitized with pClamp software (TDS-340A, Tektronic, Beaverton,
OR). By monitoring the peak-to-peak response of the population spike with the
oscilloscope, the stimulus current amplitude was adjusted to give the maximum signal
with the lowest stimulus strength. This typically resulted in stimulus currents between
0.2 and 0.9 mA. Baseline responses were recorded to assure slice quality and viability.
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Figure 8: Image of a hippocampal slice on recording stage. Single line labeled
“Recording” shows the placement of the glass microelectrode within the in the pyramidal
cell layer of CA1. The two lines labeled “Stimulation” point to the bipolar stimulating
electrodes placed in the stratum radiatum of the CA3. The subiculum, dentate gyrus, and
entorhinal cortex are labeled for orientation.
.
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CA3

Imaging
Slices were transluminated from below with white light from a DC-regulated
illuminator (PL-900 Dolan-Jenner, Boxborough, MA) and viewed with an upright stereo
microscope (SMZ 800, Nikon, Melville, NY). Slice images were acquired at 10-sec
intervals using a charge-coupled device (CCD) fixed gain camera with 640 x 480 pixel
spatial resolution and 8-bit intensity resolution (maximum of 255 units). Images were
captured and a region of interest (ROI) in the stratum radiatum of CA1 between the
stimulation and recording electrodes was selected using ImageJ software. The average
pixel intensity within the ROI was calculated to indicate the magnitude of light
transmission through the slice. The intensity of the illuminating light source was adjusted
to give an average intensity in the ROI of approximately 120 units at the start of
recordings. Baseline images were taken prior to drug treatment. All experiments were
performed in a darkened room to prevent reflected light from other sources from
interfering with the transmitted light signal.

Drug application
For some experiments, isotonic aCSF was modified to block synaptic activity in
the slices by reducing the concentration of CaCl2 to 0.2 mM and increasing the
concentration of MgSO4 to 11.4 mM. Depending on the drug used. isotonic aCSF,
DMSO, or 95% ethanol were used as vehicles for stock solutions. For AMPAR
inhibition, slices were perfused with 25 µM CNQX for 20 min prior to beginning the
stimulation train. We found this was sufficient time to completely block population field
potentials. Slices exposed to NMDAR inhibitors were perfused 15 min with 10 µM
MK801 prior to the stimulation train. Effects of complete iGluR inhibition was
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investigated by perfusing slices with a combination of both 25 µM CNQX and 10 µM
MK801 for 20 min prior to beginning the stimulation train. Slices used to study glutamate
uptake inhibition were perfused with 1 µM TBF-TBOA for 20 min prior to beginning the
stimulation train. Slices exposed to the VRAC inhibitors, 20 µM DCPIB, 100 µM
niflumic acid, or 100 µM NPPB were perfused with for 15 min prior to the start of the
stimulation train. When used, drugs also were present throughout the stimulation train
and during the subsequent 15 min recovery period.

Experimental design
Figure 9 illustrates the typical experimental design for taurine-loaded slices
treated with a drug. During time of taurine perfusion on the recording stage stimulating
and recording electrodes were placed in the slice. Stimulation and image recording began
during the taurine perfusion period. Immediately following perfusion with taurine, slices
were exposed to a drug treatment for 15-20 min before the start of a high frequency
stimulation train. Image and electrophysiological data collected during the experiments
were archived on a network server and transferred at the end of the day to a personal
computer for analysis.
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Figure 9: Schematic of experiment timeline. The experimental design of a typical taurineloaded slice involved changes in stimulation and perfusion. When a drug was not used,
isotonic aCSF replaced the period of drug perfusion. Stimulation frequencies during the
experiment are shown in boxes above the arrow. Changes in the composition of the
perfusion solution that occurred during an experiment are shown inside the arrow. The
approximate time period of each event is shown within its corresponding box.
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15 min
1/30 sec
stimulation

Field potential analysis
A Gaussian low pass filter with a cut off of 5 kHz was applied to the
electrophysiological signals prior to digital acquisition by pClamp software. To examine
drug effects on the stimulation-induced field potentials, the magnitude of the population
spike was calculated by measuring the peak-to-peak amplitude at the population spike
signal. The mean amplitude was calculated by averaging results from 5 sequential records
over a 2.5 min time interval. These mean amplitudes were calculated at several time
periods throughout the experiment: prior to drug treatment, at the end of drug loading, at
the end of high frequency stimulation, and at the end of the experiment.

Image analysis
The average intensity of the ROI in the hippocampal slice acquired during the
minute prior to the beginning of high frequency stimulation train was averaged to use as a
baseline to normalize measurements from each of the following ROI values (Figure 10).
The resulting normalized values thus describe the fractional change in light transmittance
of the slice over time. The change in light transmittance within the selected ROI was
graphed to characterize changes that occurred during high frequency synaptic activity and
pharmacological treatments. NIH Image software was used to normalize each
hippocampus slice image on a pixel-by-pixel basis to the average of seven images
acquired during the minute prior to high frequency stimulation. A pseudocolor intensity
scale was applied to these normalized images to display regional changes in light
transmittance (Figure 11).
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Intrinsic optical signal (IOS) analysis
In order to gain insight into how brain activity effects the movement of water
between intracellular and extracellular compartments, we used the change in light
absorption to provide an indirect measure of volume changes. Intrinsic optical signals
(IOSs) refer to changes in optical properties of an unstained biological tissue measured as
a change of either light transmittance or reflectance. Previous studies have shown that
cellular swelling is associated with decreased light scattering, decreased reflectance, and
increased light transmittance through biological tissue samples (MacVicar and Hochman,
1991; Andrew and MacVicar, 1994; Andrew et al., 1996; Aitken et al., 1999; Andrew et
al., 1999; Muller and Somjen, 1999; Bahar et al., 2000; Fayuk et al., 2002; Tucker and
Olson, 2010; Pal et al., 2013). In these studies, light transmission of the ROI was used to
determine the IOS. IOS has been used to indirectly measure brain tissue volume changes
in brain tissue slices
To characterize IOSs during high frequency stimulation, several measurements
were taken during the time course of an experiment. These include: on-set slope,
maximum IOS, time point of the maximum IOS, off-set slope, and the value measured 15
min after the high frequency stimulation train was terminated (Figure 10). For slices
exposed to the same treatment, measurements of each parameter were averaged and the
standard error of the mean (SEM) was calculated.
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Figure 10: Schematic of measured IOS Parameters. A) Baseline region used to normalize
light transmission signals. B) Region of IOS highlighted with a blue bar to show the
linear approximation used to calculate the on-set slope. C) Region of IOS recorded for
the maximum change in IOS. D) Region where the time at maximum IOS was recorded.
E) Region of IOS highlighted with a blue bar to show the linear approximation used to
calculate the off-set slope. F) Region where IOS recovery was measured 15 min after the
high frequency stimulation train was terminated.
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Figure 11: Colorized hippocampus slice image. The pseudocolor intensity scale
represents percent change in IOS from baseline (black regions indicate no change in
IOS). A) Baseline slice image before initiation of high frequency stimulation indicates no
change in IOS. B) Slice during high frequency stimulation displays increased IOS along
the SC pathway.
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Figure 11:
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On-set slope
The on-set slope corresponds with the initial change in IOS observed at the start
of high frequency stimulation. It was derived as the slope of a linear approximation
calculated from 2-3 normalized IOS values. The number of values chosen to calculate onset slope was determined as the number of points which yielded the minimum coefficient
of variation across experiments. The mean on-set slope was calculated for each treatment
along with the SEM of these mean values.
Maximum IOS and corresponding time
During the high frequency stimulation train, the maximum IOS and the time at
which the maximum IOS point occurred was recorded. The time at which the maximum
IOS point occurred is expressed relative to the beginning of the high frequency
stimulation train. The mean maximum IOS and time point were calculated for each
treatment along with the standard error of mean of these mean values
Off-set slope
The off-set slope measurement began immediately after the high frequency
stimulation and consisted of a linear approximation of 2-6 values. The number of values
chosen to calculate off-set slope was determined as the number of points which yielded
the minimum coefficient of variation across experiments. The mean off-set slope was
calculated for each treatment along with the SEM of these mean values.
IOS recovery
IOS was measured for each slice 15 min after the end of the high frequency
stimulation train to get a measure of recovery. Slices used to study stimulation-frequency
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were only given 5 min of recovery following the stimulation train. Thus IOS recovery
was taken 5 min after the end of stimulation for these initial experiments. The mean IOS
recovery was calculated for each treatment along with the SEM of these mean values.

Statistical analysis
Quantitative data are presented as the mean values ± SEM. Amplitude values
from electrophysiological recordings and IOS values were analyzed for statistical
significance using a one-way ANOVA with Dunnett's post hoc analysis for multiple
comparisons. A two-way ANOVA without replication with Dunnett’s post hoc analysis
was used in the analysis of IOS during iGluR inhibition. For some studies, the nonparametric Mann-Whitney U test was used if data was not normally distributed. Values
were considered significantly different for p < 0.05.
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V. RESULTS
Hippocampal volume response to stimulation is frequency dependent
The Schaffer collateral pathway was stimulated at 1, 3, 5, and 10 Hz for 5 min. In
slices without taurine treatment, the magnitude of changes in light transmission through
the slice increased as the frequency of the stimulation train increased (Figure 12). Several
parameters were taken during the time course of the experiment to characterize the
effects of stimulation frequency on IOS. The on-set slope, taken from the start of high
frequency stimulation was calculated for each frequency change. The on-set slope was
significantly different from baseline at 10 Hz stimulation but not for lower frequencies
(Figure 13). The off-set slope, taken at the end of high frequency stimulation, was
significantly different from baseline at 10 Hz (Figure 13). The maximum change in IOS
increased with increased stimulation; however, the maximum change in IOS from the
baseline and the time at which the maximum occurred were not significant at any
frequency (Table 1). The IOS measured after 5 min of recovery was not significantly
different from the baseline value at any frequency.
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Figure 12: Effects of stimulation frequencies on IOS. Slices were stimulated at the
frequencies shown and slice images acquired every 10 sec. Values are the mean ± SEM
of 5-6 slices. Some error bars for individual time points are removed for clarity.
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Figure 13: On-set slope and off-set slope measured at different stimulation frequencies.
* Indicates values which are significantly different from baseline by a one-way ANOVA
(p<0.05) and Dunnett’s post hoc test.
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Figure 13:

*

*

64

Table 1: Effect of stimulation frequency on maximum IOS, time at the maximum IOS,
and IOS recovery after 5 min. Values are the mean ± SEM from 5-6 hippocampal slices.
No values were significantly different from baseline by a one-way ANOVA (p<0.05) and
Dunnett’s post hoc test.
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Table 1:
Maximum

Time at

Stimulation

Last min of IOS
change in IOS

Maximum IOS

Frequency

(% from baseline)
(% from baseline)

(min)

1 Hz

0.23 ± 0.11

0.92 ± 0.72

0.28 ± 0.57

3 Hz

0.73 ± 0.53

1.37 ± 0.75

-0.48 ± 0.31

5 Hz

1.68 ± 1.21

1.06 ± 0.53

-0.34 ± 1.06

10 Hz

2.52 ± 1.40

1.72 ± 0.87

1.26 ± 1.29
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Synaptic blockage inhibits stimulation-induced swelling
Population field potentials
A synaptic block solution (SBS) was created by modifying aCSF with low Ca+
and high Mg+ concentration. Slices were perfused with the SBS 10 min prior to high
frequency stimulation and throughout the period of high frequency stimulation and
recovery. Field potential recordings were used to verify that the slice was synaptically
blocked. Figure 14 shows the field potential at several time periods during the course of
the experiment. The mean amplitude of the population spike measured over 2.5 min prior
to SBS perfusion was 2.34 ± 0.17mV. The amplitude remained significantly reduced
from the baseline amplitude throughout SBS exposure. The amplitude was reduced at the
end of the 10 min perfusion to 1.17 ± 0.22mV. During the last half of the high frequency
stimulation, the amplitude decreased further to 1.01 ± 0.15mV. By the end of the
experiment, the amplitude had increased somewhat to 1.12 ± 0.21mV but did not recover
to the baseline amplitude.
Stimulation-induced changes in IOS
IOS responses to stimulation were reduced in slices perfused with SBS and
remained relatively unchanged following the high frequency stimulation (Figure 15).
There was a significantly reduced on-set slope in synaptically blocked slices, but the offslope was not statistically different from that measured in control slices (Figure 16). The
maximum IOS was reduced in synaptically blocked slices, but the time to reach the
maximum IOS was not statistically different (Table 2). Slices exposed to SBS did not
return towards the baseline following high frequency stimulation.
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Figure 14: Effects of synaptic block on stimulation-induced field potentials. Individual
field potentials were taken at several periods during the experiment A) Baseline field
potential taken prior to SBS exposure B) Field potential after 10 min drug loading C)
Field potential at the end of 10 Hz stimulation. D) Field potential 15 min after the end of
the 10 Hz stimulation train. Arrows point to the composite action potential spike in the
Schaffer collateral axons. The sampling interval of the individual field potential
recordings was reduced by a factor of 10. The graphed field potentials were expanded to
show the first 20 ms of the recording data for clarity purposes.
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Figure 15: Effect of synaptic block on stimulation-induced changes in IOS. Values are
the mean ± SEM of 5-7 slices. Some error bars for individual time points are removed for
clarity.
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Figure 15:
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Figure 16: On-set slope and off-set slope measured with perfusion with synaptic block
solution. Values are the mean ± SEM of 5-7 slices. * Indicates values which are
significantly different from control by a one-way ANOVA (p<0.05) and Dunnett’s post
hoc test.
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Figure 16:
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Table 2: Effect of SBS on maximum IOS, time at maximum IOS, and last min of IOS.
Values are the mean ± SEM from 5-7 hippocampal slices. * Indicates values which are
significantly different from control by a one-way ANOVA (p<0.05) and Dunnett’s post
hoc test or Mann-Whitney U test.
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Table 2:
Maximum

Time at
Last min of IOS

Group

change in IOS

Maximum IOS
(% from baseline)

(% from baseline)

(min)

Control

6.22 ± 1.61

4.69 ± 0.19

3.47 ± 1.43

SBS

1.99 ± 0.34*

3.63 ± 0.76

2.08 ± 1.16
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iGluR inhibtions does not alter stimulation-induced changes in IOS
Population field potentials
Hippocampal slices were exposed to 25 µM CNQX or 10 µM MK801 to examine
the role of glutamate AMPA or NMDA signaling, respectively, for stimulation-induced
swelling and volume regulation. Complete inhibition of iGluRs was achieved with
perfusion of both 25 µM CNQX and 10 µM MK801 in the aCSF. Control slices were
exposed to aCSF containing 0.1% DMSO, the vehicle used to make stock solutions of
CNQX and MK801. Field potential recordings were used to verify viability of the slice
and inhibition of AMPA receptors. In the presence of CNQX, the population spike
amplitude was significantly reduced in the electrophysiological recordings following 20
min of CNQX perfusion. Figure 17 shows several field potentials recorded during the
course of a CNQX experiment. Perfusion with MK801 did not significantly impact the
amplitude of the population spike except during the high frequency stimulation (Figure
18). In the presence of CNQX and MK801, the amplitude was significantly reduced
throughout the experiment following the 20 min perfusion (Figure 19). Table 3 shows the
calculated amplitudes prior to drug exposure, at the end of drug loading, at the end of the
high frequency stimulation, and at the end of the experiment.
Stimulation-induced changes in IOS
The stimulation-induced IOS responses of slices perfused with CNQX were
similar to that measured in slices perfused with drug vehicle (Figure 20). In contrast,
slices perfused with MK801 showed a reduced IOS response (Figure 21). Perfusion with
the combination of CNQX and MK801 to block all iGluRs also reduced the stimulationinduced change in IOS (Figure 22). Inhibition of iGluRs decreased the IOS rate of change
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for the on-set and off-set slopes (Figure 23). The inhibition of AMPARs did not slow the
rate of change as much as inhibition of NMDARs. During total iGluR inhibition, there
was an additive effect on the IOS rate of change. In the presence of CNQX, the peak
typically occurred later during the high frequency stimulation train. During the last min
of images, the IOS was similar to controls for all drug treatments. With NMDA inhibition
alone, the IOS maximum was significantly reduced. Total iGluR inhibition also tended to
reduce the maximum IOS change but the value was not statistically different from
controls. Table 4 summarizes effects of iGluR inhibition on the maximum IOS and when
this peak occurred relative to the start of high frequency stimulation.
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Figure 17: Effects of CNQX on stimulation-induced field potentials. Individual field
potentials were taken at several periods during the experiment A) Baseline field potential
taken prior to CNQX exposure B) Field potential after 20 min of drug loading C) Field
potential at the end of 10 Hz stimulation. D) Field potential 15 min after the end of the 10
Hz stimulation train. The sampling interval of the individual field potential recordings
was reduced by a factor of 10. The graphed field potentials were expanded to show the
first 20 ms of the recording data for clarity purposes.
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Figure 18: Effects of MK801 on stimulation-induced field potentials. Individual field
potentials were taken at several periods during the experiment A) Baseline field potential
taken prior to MK801 exposure B) Field potential after 15 min of drug loading C) Field
potential at the end of 10 Hz stimulation. D) Field potential 15 min after the end of the 10
Hz stimulation train. The sampling interval of the individual field potential recordings
was reduced by a factor of 10. The graphed field potentials were expanded to show the
first 20 ms of the recording data for clarity purposes.
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Figure 19: Effects of total iGluR inhibition on stimulation-induced field potentials.
Individual field potentials were taken at several periods during the experiment A)
Baseline field potential taken prior to CNQX+MK801 exposure B) Field potential after
20 min of drug loading C) Field potential at the end of 10 Hz stimulation. D) Field
potential 15 min after the end of the 10 Hz stimulation train. The sampling interval of the
individual field potential recordings was reduced by a factor of 10. The sampling interval
of the individual field potential recordings was reduced by a factor of 10. The graphed
field potentials were expanded to show the first 20 ms of the recording data for clarity
purposes.
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Table 3: Effects of iGluR inhibition on population spike amplitude. Values are the mean
± SEM from 3-6 hippocampal slices. * Indicates values which are significantly different
from baseline amplitude by a one-way ANOVA (p<0.05) and Dunnett’s post hoc test.
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Table 3:

Group
CNQX
MK801
CNQX +
MK801

4.19 ± 1.40
4.42 ± 0.53

End of drug
loading
amplitude
(mV)
1.02 ± 0.1 *
4.57 ± 0.54

End of 10 Hz
train
amplitude
(mV)
0.75 ± 0.07 *
1.24 ± 0.12 *

End of
experiment
amplitude
(mV)
1.01 ± 0.08 *
4.55 ± 0.42

4.29 ± 0.56

1.12 ± 0.05 *

0.88 ± 0.12 *

1.27 ± 0.32 *

Baseline
amplitude
(mV)
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Figure 20: Effects of CNQX on stimulation-induced changes in IOS. Values are the mean
± SEM of 4-5 independent measurements. Some error bars for individual time points are
removed for clarity.

86

Figure 20:
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Figure 21: Effects of MK801 on stimulation-induced changes in IOS. Values are the
mean ± SEM of 4 independent measurements. Some error bars for individual time points
are removed for clarity.
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Figure 21:

*
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Figure 22: Effects of total iGluR inhibition on stimulation-induced changes in IOS.
Values are the mean ± SEM of 4 independent measurements. Some error bars for
individual time points are removed for clarity.
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Figure 22:
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Figure 23: Measured on-set slope and off-set slope with iGluR inhibition. * Indicates
values which are significantly different from the vehicle by a two-way ANOVA (p<0.05)
and Dunnett’s post hoc test.
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Figure 23:
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Table 4: Effect of iGluR inhibition on maximum IOS, corresponding time at maximum
IOS, and last min of IOS. Values are the mean ± SEM from 4-5 hippocampal slices. *
Indicates values which are significantly different from the vehicle by a two-way ANOVA
(p<0.05) and Dunnett’s post hoc test.
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Table 4:

Groups

Maximum IOS
(% from baseline)

Vehicle
CNQX
MK801
CNQX + MK801

7.34 ± 0.79
8.75 ± 2.66
3.69 ± 0.82 *
4.41 ± 1.35

Time at Maximum
IOS
(min)
3.00 ± 0.52
4.73 ± 0.30 *
1.38 ± 0.79
4.58 ± 0.26
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Last min of IOS
(% from baseline)
1.68 ±
1.96 ±
1.45 ±
1.52 ±

0.87
0.99
0.88
0.24

Glutamate uptake inhibition prevents stimulation-induced swelling
Population field potentials
TFB-TBOA was used to inhibit glutamate uptake during high frequency
stimulation. The population spike amplitude increased after 15 min of perfusion with
1µM TFB-TBOA from 2.75 ± 0.86 mV to 3.51 ± 0.62 mV. The number of repetitive
population spikes with low frequency stimulation also was observed to increase during
TFB-TBOA perfusion. During high frequency stimulation, the population spike
amplitude was reduced to 1.89 ± 0.33 but recovered by the end of the experiment to 3.48
± 0.61mV. Figure 24 shows several field potential taken throughout a typical TFB-TBOA
experiment.
Stimulation-induced changes in IOS
TFB-TBOA perfusion reduced stimulation-induced changes in IOS (Figure 25).
The on-set slope at the start of high frequency stimulation with TFB-TBOA perfusion
was greatly reduced compared to that observed in control slices (p<0.01) (Figure 26).
Although the maximum change in IOS during high frequency stimulation was reduced
compared to that observed in slices with only drug vehicle, this difference was not
significant. In TFB-TBOA slices, the maximum IOS appeared 1.83±0.74 min into the
high frequency stimulation train which was 39% earlier than in control slices but not
significant. Upon termination of the high frequency stimulation train, slices exposed to
TFB-TBOA experienced a lower off-set slope at 3.00±1.58%/min compared with slices
perfused with vehicle, but this difference was not statistically significant (Figure 26). The
last min of IOS was not significantly different between slices perfused with TFB-TBOA
and control slices.
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Figure 24: Effects of TFB-TBOA on stimulation-induced field potentials. Individual field
potentials were taken at several periods during the experiment. A) Baseline field potential
taken prior to TFB-TBOA exposure. B) Field potential after 15 min of drug loading. C)
Field potential at the end of 10 Hz stimulation. D) Field potential 15 min after the end of
the 10 Hz stimulation train. The sampling interval of the individual field potential
recordings was reduced by a factor of 10. The graphed field potentials were expanded to
show the first 20 ms of the recording data for clarity purposes.
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Figure 25: Effects of TFB-TBOA on stimulation-induced changes in IOS. Control slices
were exposed to aCSF with DMSO, the vehicle for TFB-TBOA. Values are the mean ±
SEM of 4 independent measurements. Some error bars for individual time points are
removed for clarity.

99

Figure 25:
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Figure 26: Measured on-set slope and off-set slope with TFB-TBOA exposure. *
Indicates values which are significantly different from those obtained from slices
perfused with vehicle by a one-way ANOVA (p<0.05) and Dunnett’s post hoc test.
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Figure 26:

*

102

VRAC inhibition does not affect stimulation-induced changes in IOS
Population field potentials
Three drugs were used to inhibit of VRAC during high frequency stimulation. In
the presence of niflumic acid or NPPB, the field potentials and population spike
amplitude did not significantly change (Figures 27 and 28). In the presence of DCPIB,
the population spike amplitude was increased following 20 min of perfusion (Figure 29).
For all of these drugs, the population spike amplitude decreased during high frequency
stimulation but showed at least partial recovery after the stimulation train was terminated
(Table 5) possibly due to an exhausted supply of glutamate. Table 5 shows the mean
population spike amplitudes prior to drug exposure, at the end of drug loading, at the end
of the high frequency stimulation, and at the end of the experiment.
Stimulation-induced changes in IOS
Due to the differences in drug vehicle used, each VRAC inhibitor had different
control series of slices for comparison. IOS responses of slices perfused with niflumic
acid were similar to the control (Figure 30). Slices perfused with NPPB showed an
elevated IOS response compared with their respective control slices (Figure 31);
however, inhibition of VRACs with DCPIB significantly decreased the overall IOS
response (Figure 32). The on-set slope and off-set slope for slices perfused with niflumic
were similar to those measured in relevant control slices (Figure 33). The on-set slope of
NPPB was similar to that measured in slices perfused with vehicle only but the off-set
slope was significantly different (Figure 34). DCPIB perfusion significantly decreased
both on-set and off-set slopes (Figure 35). Table 6 shows the effects of VRAC inhibition
with the three drugs on the maximum IOS and the time at which the maximum IOS
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occurred relative to the start of high frequency stimulation. IOS recovery measured 15
min after the end of high frequency stimulation was significantly reduced only for slices
perfused with DCPIB (p<0.01). Niflumic acid and NPPB did not influence the maximum
IOS but instead significantly delayed the time when the maximum occurred during high
frequency stimulation (p<0.05 and p<0.01 respectively). The recovery IOS was reduced
in niflumic acid to 1.18±0.49% above baseline compared to the control at 3.47±1.43%
above baseline. Recovery IOS in the presence of NPPB was elevated to 3.33±1.23%
above baseline compared to the ethanol vehicle at 0.24±0.75% above baseline. Exposure
to DCPIB significantly reduced the recovery IOS (p<0.05) to 1.41±0.72% above
baseline.
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Figure 27: Effects of niflumic acid on stimulation-induced field potentials. Individual
field potentials were taken at several periods during the experiment A) Baseline field
potential taken prior to niflumic acid exposure B) Field potential after 15 min of drug
loading C) Field potential at the end of 10 Hz stimulation. D) Field potential 15 min after
the end of the 10 Hz stimulation train. The sampling interval of the individual field
potential recordings was reduced by a factor of 10. The graphed field potentials were
expanded to show the first 20 ms of the recording data for clarity purposes.
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Figure 28: Effects of NPPB on stimulation-induced field potentials. Individual field
potentials were taken at several periods during the experiment A) Baseline field potential
taken prior to NPPB exposure B) Field potential after 15 min of drug loading C) Field
potential at the end of 10 Hz stimulation. D) Field potential 15 min after the end of the 10
Hz stimulation train. The sampling interval of the individual field potential recordings
was reduced by a factor of 10. The graphed field potentials were expanded to show the
first 20 ms of the recording data for clarity purposes.
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Figure 29: Effects of DCPIB on stimulation-induced field potentials. Individual field
potentials were taken at several periods during the experiment A) Baseline field potential
taken prior to DCPIB exposure B) Field potential after 15 min of drug loading C) Field
potential at the end of 10 Hz stimulation. D) Field potential 15 min after the end of the 10
Hz stimulation train. The sampling interval of the individual field potential recordings
was reduced by a factor of 10. The graphed field potentials were expanded to show the
first 20 ms of the recording data for clarity purposes.
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Table 5: Effects of VRAC inhibition on population spike amplitude. * Indicates values
which are significantly different from the baseline amplitude by a one-way ANOVA
(p<0.05) and Dunnett’s post hoc test or a Mann-Whitney U test.
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Table 5:

Baseline
Group

amplitude
(mV)

End of drug

End of 10 Hz

End of

loading

train

experiment

amplitude

amplitude

amplitude

(mV)

(mV)

(mV)

Niflumic acid

2.77 ± 0.62

2.91 ± 0.61

1.39 ± 0.21

2.50 ± 0.50

NPPB

3.23 ± 0.49

3.37 ± 0.34

1.02 ± 0.10 *

2.55 ± 0.29

DCPIB

4.51 ± 0.72

5.87 ± 1.06

2.44 ± 0.41

6.74 ± 0.70*
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Figure 30: Effects of niflumic acid on stimulation-induced changes in IOS. The vehicle
slices were taurine-treated and perfused with aCSF. Values are the mean ± SEM of 6-7
independent observations. Some error bars for individual time points are removed for
clarity.
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Figure 30:
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Figure 31: Effects of NPPB on stimulation-induced changes in IOS. The vehicle slices
were taurine-treated and perfused with ethanol + aCSF. Values are the mean ± SEM of 45 independent observations. Some error bars for individual time points are removed for
clarity.
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Figure 31:
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Figure 32: Effects of DCPIB on stimulation-induced changes in IOS. The vehicle slices
were taurine-treated and perfused with DMSO + aCSF. Values are the mean ± SEM of 47 independent observations. Some error bars for individual time points are removed for
clarity.
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Figure 32:
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Figure 33: Measured on-set slope and off-set slope with niflumic acid exposure. *
Indicates values which are significantly different from the vehicle by a one-way ANOVA
(p<0.05) and Dunnett’s post hoc test.
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Figure 33:
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Figure 34: Measured on-set slope and off-set slope with NPPB exposure. * Indicates
values which are significantly different from the ethanol vehicle by a one-way ANOVA
(p<0.05) and Dunnett’s post hoc test.

121

Figure 34:
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Figure 35: Measured on-set slope and off-set slope with DCPIB exposure. Data values
represent mean ± SEM for 4-7 independent experiments. * Indicates values which are
significantly different from the vehicle by a one-way ANOVA (p<0.05) and Dunnett’s
post hoc test.
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Figure 35:
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Table 6: Effect of VRAC antagonists on maximum IOS, time at the maximal IOS, and
IOS value measured at the last min of the experiment. Due to differences in solubility
among the VRAC antagonists, each drug had a different control for comparison. Niflumic
acid, NPPB, and DCPB were dissolved in aCSF, ethanol, and DMSO respectively. ◊
Indicates values which are significantly different from control by a one-way ANOVA
(p<0.05) and Dunnett’s post hoc test. † Indicates values which are significantly different
from ethanol vehicle by a one-way ANOVA (p<0.05) and Dunnett’s post hoc test.*
Indicates values which are significantly different from the vehicle by a one-way ANOVA
(p<0.05) and Dunnett’s post hoc test.
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Table 6:

Groups

Maximum IOS
(% from baseline)

Vehicle
Control
Ethanol
Niflumic acid
NPPB
DCPIB

7.34 ± 0.79
6.22 ± 1.61
4.39 ± 1.19
5.63 ± 1.01
7.77 ± 1.66
2.08 ± 0.36 *

Time at Maximum
IOS
(min)
3.00 ± 0.52
4.69 ± 0.19
0.70 ± 0.35
3.17 ± 0.65 ◊
4.54 ± 0.31 †
2.55 ± 0.81
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Last min of IOS
(% from baseline)
1.68 ± 0.87
3.47 ± 1.43
0.24 ± 0.79
1.18 ± 0.49
3.33 ± 1.23
-1.41 ± 0.72 *

VI. DISCUSSION
The results of these studies elucidate mechanisms underlying stimulation-induced
swelling of neurons and glia at the glutamatergic synapse and potential sources of volume
regulation. The physiological consequence of synaptic activity results in cellular swelling
to stimulation that is largely due to NMDA activation and glutamate uptake. These
studies suggest glutamate receptor activation is a significant factor for volume regulation.
Finally, volume regulation via VRACs is minimal at most during stimulation-induced
swelling.

Volume response to stimulation is frequency dependent
During neuronal activity, axonal studies in crab leg nerves revealed light
scattering changes that were suggested to represent axon swelling resulting from the ionic
exchanges that occur during the action potential (Cohen and Keynes, 1971). Following
these studies, several investigators have observed similar changes in light transmission
during stimulation. Stimulation of rat hippocampal slices with photodiodes to detect
transmitted light also showed an association of optical signals with synaptic activity
(Grinvald et al., 1982; MacVicar and Hochman, 1991). These changes in light scattering
and transmission during electrical activity were found to be associated with cell-volume
changes (Andrew and MacVicar, 1994; Witte et al., 2001; Fayuk et al., 2002).
In this present study, stimulation of the SC pathway in most slices exhibited a
frequency related trend for the on-set slope, off-set slope, and maximum change in IOS.
These results together confirm previous findings (MacVicar and Hochman, 1991) and
demonstrate that stimulation-induced changes in IOS are related to stimulation frequency.
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Previous studies in the mouse optic nerve have found that increases in extracellular K+
are proportional to stimulation frequency (Bay and Butt, 2012). Likewise, research in the
rat cerebral cortex has revealed glutamate release is proportional to neuronal activity
(Moroni et al., 1981). Glutamate release may in turn lead to cell swelling during its reuptake into glial cells or by activating GluRs which cause cation influx into neurons and
glia. Taken together, this suggests that stimulation-induced changes of IOS are related to
stimulation frequency because uptake of extracellular K+, activation of glutamate
receptors, and glutamate uptake are proportional to stimulation frequency. Astrocytes are
predominately involved in glutamate and K+ uptake following neuronal discharge and
have been shown to swell due to this influx of osmolytes (Schneider et al., 1992;
Macaulay and Zeuthen, 2012). A previous study measuring IOS changes in the CA1 str.
rad. found that IOS changes were proportional to the level of hypo-osmolality (Andrew
and MacVicar, 1994) which would indicate that cellular influx of water is proportional to
intracellular osmolytes which drive water influx. Overall, these findings support the
notion that changes in IOS indicate cellular swelling proportional to the influx of K+,
glutamate, and cation influx via GluR which is dictated by the level of synaptic activity.
Interestingly, slices stimulated at 1 Hz exhibited an initial decrease in IOS. This
finding might indicate initiation of regulatory volume mechanisms during stimulation that
can over compensate during low levels of activity. A study in the optic nerve revealed
that stimulation of nerves at 1 Hz did not evoke a change of extracellular K+, indicating
K+ efﬂux and uptake were in balance at low levels of activity (Ransom et al., 2000; Bay
and Butt, 2012) and thus, would not result in water influx and cellular swelling. During
low levels of activity, the movement of K+ and glutamate between the intracellular and
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extracellular compartments causes negligible water movement therefore no cellular
swelling. Glutamate-mediated regulatory volume mechanisms initiated during low-levels
of synaptic activity would reduce cellular volume of non-swollen cells. These events
could explain the reduced IOS during stimulation at 1Hz in the present study.

Synaptic blockage inhibits stimulation-induced swelling
Orthodromic stimulation of the SC pathway evokes action potentials of CA3
pyramidal cell axons resulting in an influx of Na+, Ca+2, and efflux of K+. Elevated
intracellular Ca+2 via voltage-gated Ca+2 channels facilitates synaptic vesicle release
which can be blocked by polyvalent cations such as Mn+2, Co+2, and Mg+2 (Taft and
DeLorenzo, 1987). In the present study, low extracellular Ca+2 and high extracellular
Mg+2 were used to block voltage-gated Ca+2 channels and thus block intracellular Ca+2
influx and glutamate release. Synaptic blockage was confirmed by measuring field
potentials that indicated the presence of only presynaptic activation of the SC pathway
and no postsynaptic response in synaptic block conditions (Figure 14).
During synaptic blockage, action potentials cause K+ accumulation in the
extracellular and periaxonal space (Kiernan et al., 1997) which is predominantly cleared
by astrocytes and results in a cellular influx of water (Kofuji and Newman, 2004).
Additionally, neurons experience an influx of Na+ resulting in neuronal swelling
(Churchwell et al., 1996). In this study, synaptic blockage of the SC pathway
significantly reduced stimulation-induced changes in IOS. Similar results were reported
with Ca+2-free EGTA perfusate of hippocampal slices (MacVicar and Hochman, 1991).
Antidromic stimulation, which initiates action potentials in the axon without synaptic
activity also showed reduced changes in IOS in hippocampal slices (Andrew and
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MacVicar, 1994). In the presence of tetrodotoxin, a potent neurotoxin that blocks
voltage-gated sodium channels, there is no change in IOS present in hippocampal slices
indicating that generation of action potentials is necessary for the observed cellular
swelling (Pal et al., 2013). These findings together imply that while there is some K+ and
Na+ induced swelling during SC activation, the majority of cellular swelling is a
consequence of Ca+2 influx and/or glutamate release.
Under perfusion with normal aCSF, glutamate release may in turn lead to cell
swelling during its re-uptake into glial cells or by activating post-synaptic glutamate
receptors. Glutamate mediated swelling via GluR activation is well known and
associated with multiple pathophysiological conditions (Andrew et al., 1996; Arundine
and Tymianski, 2004; Kimelberg, 2004a; Liang et al., 2007; Ho et al., 2012). For
example, Ca+2 accumulations by GluR activation is involved in hippocampal cell damage
associated with ischemia (Benveniste et al., 1988; Lobner and Lipton, 1993) which
results in cellular swelling (Zhang et al., 2011).
Synaptic blocked slices exhibited a lack of recovery following stimulationinduced changes in IOS. These findings indicate that intracellular Ca+2, glutamate release,
and/or GluR activation might be involved in volume regulatory mechanisms during
neuronal activity. Ca+2 signaling activates Ca+2-sensitive protein kinases (Bender et al.,
1992; Crepel et al., 1998), Ca+2 dependent ion channels (Scemes and Giaume, 2006), and
gliotransmitters (Zorec et al., 2012), each of which can potentially mediate RVD. In
most cell types, including neurons and astrocytes, influx of Ca2+ precedes RVD
suggesting that it serves as a second messenger for effector proteins (Hua et al., 2010).
Increases in intracellular Ca+2 are required for activation of neuronal volume-regulatory
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pathways following swelling caused by Na+ influx (Churchwell et al., 1996). Likewise,
RVD mechanisms are Ca+ dependent in cultured astrocytes (Olson et al., 2004; Benfenati
et al., 2011). There also is evidence of Ca+2 signaling of NMDA-induced taurine efflux
during volume regulation in hippocampal slices (Menendez et al., 1993).
Synaptically released glutamate also may be an important signal that initiates
volume regulatory mechanisms. Glutamate activation of all three iGluRs has been found
to commence taurine efflux (Oja and Saransaari, 2013b). In synaptically blocked slices,
none of the glutamate receptors would be able to initiate taurine efflux and this could
explain the lack of recovery IOS. Glutamate mediated volume regulation through
purinergic signaling has also been shown in numerous studies during osmotic challenges
of retinal glial cells (Kalisch et al., 2006; Wurm et al., 2008; Wurm et al., 2010; Linnertz
et al., 2011). These studies showed glutamate activation of mGluR , which causes Ca+2
influx, resulted in ATP release that initiated purinergic signaling pathways to facilitate
ion and taurine effluxes. Synaptically blocked slices would be unable to activate mGluR
and start purinergic signaling cascades for volume regulation. Taken together, previous
research supports the notion that Ca+2 and glutamate can potentially mediate regulation of
cellular volume during stimulation-induced swelling.
Results in conjunction with past research suggests stimulation-induced swelling is
mainly an outcome of synaptic glutamate release which leads to glutamate uptake from
the extracellular space into astrocytes as well as an influx of cations into neurons and
astrocytes via glutamate receptors. Subsequently, glutamate mediates a volume
regulatory mechanism likely associated to taurine efflux, Ca+2 –dependent processes, or
purinergic signaling.
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iGluR inhibition affects stimulation-induced changes in IOS
The activation of iGLuRs causes an influx of Na+, K+, and Ca+2 into neurons and
glia (Mano and Teichberg, 1998; Pinheiro and Mulle, 2006; Kalia et al., 2008; Langer
and Rose, 2009). This influx of osmolytes would be expected to cause cellular swelling.
Various studies have demonstrated activity dependent swelling in hippocampus slices
during stimulation. Orthodromic stimulation and kainate application increase IOS in
hippocampus revealing cellular swelling associated with excitatory synaptic input
(Andrew and MacVicar, 1994). Additionally, application of the glutamate agonist
NMDA increases IOS in the rat hippocampal slices, particularly in the CA1 region (Jarvis
et al., 1999). Further studies showed that blockade of iGluRs with kynurenic acid
inhibited hippocampal changes in IOS (MacVicar and Hochman, 1991).
Inhibition of AMPARs and NMDARs were examined with the application of
CNQX and MK-801, a competitive antagonist at non-NMDA glutamate receptors
(Honore et al., 1988; Andreasen et al., 1989) and non-competitive antagonist that blocks
the channel pore of NMDARs (Lau and Tymianski, 2010), respectively. The inhibition of
AMPAs was confirmed by field potential recordings that displayed reduced population
spike amplitude.
AMPAR inhibition did not the affect the maximum change in stimulation-induced
IOS while NMDAR inhibition significantly reduced the maximum change in IOS (Table
4). These results suggest that the NMDARs contribute to hippocampal swelling induced
by synaptic activation while AMPARs have little to no effect. Similarly, AMPA
inhibition with NBQX did not block glutamate-induced swelling in astrocyte cultures
(Hansson et al., 1994). Reduced IOS with complete iGluR inhibition was likely due to
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NMDAR inhibition. Stimulation-induced swelling via NMDARs might be associated
with increased Ca+2 permeability of the postsynaptic membranes. Mouse cortical neuron
cultures treated with NMDA demonstrated Ca+2 influx via NMDARs. This leads to the
activation of kinases, which in turn phosphorylates NOX2, increases superoxide
production and induces cellular swelling from oxidative stress (Brennan-Minnella et al.,
2013). Cellular swelling from oxidative stress has also been demonstrated in hippocampal
slices (Tucker and Olson, 2010).
AMPAR and NMDAR inhibition hindered recovery of IOS at the termination of
stimulation while complete iGluR inhibition with both drugs present resulted in an
additive effect on cellular volume regulation (Figure 23). This inhibition of recovery with
the application of iGluRs implies that glutamate-mediated volume regulation involves
activation of iGluR during electrical activity. Overall, these findings suggest that only
NMDARs contribute to stimulation-induced swelling of the hippocampus while both
iGLuRs mediate cellular volume recovery mechanisms during neuronal activity.
NMDAR activation has been linked to volume regulation by facilitating taurine efflux
during oxidative stress (Tucker and Olson, 2010; Oja and Saransaari, 2013b). It is
possible that Ca+2 influx via NMDARs could signal volume regulatory mechanisms via
kinases and Ca+2 activated ion channels. The involvement of Ca+2 in RVD responses
following cell swelling has been found in many cell systems, particularly those of
epithelial origin but not as of yet in neuronal cells (Hoffmann et al., 2009)

Glutamate uptake inhibition reduced IOS response
Although GluTs are expressed by all CNS cell types, astrocytes are the cell type
primarily responsible for glutamate uptake (Bergles and Jahr, 1998; Anderson and
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Swanson, 2000). Absence of GluTs results in excessive activation of GluRs, abnormal
neuronal activity, and eventual excitotoxic degeneration (Rothstein et al., 1996; Tanaka et
al., 1997). Several studies have shown TFB-TBOA to potently inhibit glutamate uptake.
This drug can be used to selectively target different glial GluTs at nanomolar
concentration levels (Shimamoto et al., 2004; Tsukada et al., 2005; Bozzo and Chatton,
2010; Torres et al., 2013). In this present study, 1 µM of TFB-TBOA was used to
effective block all GluTs.
During stimulation-induced volume changes, inhibition of GluTs with TFBTBOA increased the population spike amplitude suggesting glutamate persistence in the
synaptic space was influencing neuronal excitability (Figure 24). Increased changes in
IOS would indicate that neuronal activity contributes to cellular volume changes more
than glutamate uptake. However, glutamate inhibition reduced changes in IOS indicating
cellular volume changes due to neuronal activity have minimal effect compared to
glutamate uptake. These results indicating glutamate uptake induced swelling are similar
to results from a previous study that showed EAAT2 inhibition, the most prominent
GluTs in the str. rad of CA1 (Lehre and Danbolt, 1998), reduced IOS amplitude (Pal et
al., 2013). GluTs uptake of one glutamate molecule is thermodynamically coupled with
the influx of three Na+, one H+, and the efflux of one K+ (Lopez-Bayghen and Ortega,
2011; Stone et al., 2012) thus cation influx should be impaired with GluT inhibition. Na+
is an important osmolyte that can drive water influx. The majority of Na+ infux in
astrocytes is mediated by GluT activation (Langer and Rose, 2009). These results joined
with other studies suggest that glutamate and Na+ influx via GluTs contribute to glial
swelling during neuronal activity.
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VRAC inhibition does not affect stimulation-induced changes in IOS
Efflux of intracellular Cl- coupled with K+ is one of the main contributors to RVD
(Hoffmann et al., 2009). It is accepted that many cells regulate their volume through cell
swelling-activated VRAC that generates RVD through efflux of Cl- and small organic
osmolytes (Kimelberg et al., 2006). VRACs are also permeable to water in addition to
various organic anions such as taurine (Nilius, 2004; Tucker and Olson, 2010). During
excitotoxic conditions, VRACs are responsible for the persistence of dendritic beadings
and neuronal swelling in cultured cortical neurons (Inoue and Okada, 2007). In hypoxicischemic conditions, inhibition of VRACs is neuroprotective by blocking glutamate and
taurine efflux (Feustel et al., 2004; Kimelberg et al., 2004; Zhang et al., 2008; Alibrahim
et al., 2013).
There is wide source of pharmacological inhibitors for VRACs including NPPB,
niflumic acid, and DCPIB. These pharmacological agents were used separately in this
present study to examine the effects of VRAC on stimulation-induced changes in IOS.
VRAC inhibition during stimulation produced inconsistent results with these various
drugs. Inhibition of VRACs with NPPB increased the maximum IOS response and
delayed IOS recovery suggesting that VRACs are vital for volume regulation during
stimulation induced swelling (Figure 31). In contrast, VRAC inhibition with niflumic
acid produced IOS changes similar to the control suggesting the absence of VRAC
involvement during synaptic activity (Figure 30). Finally, VRAC inhibition with DCPIB
significantly decreased initial, maximum, and recovery IOS responses suggesting VRACs
contribute to stimulation induced volume changes (Figure 32). The conflicting results
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imply that various effects of these vehicles and drugs on cellular components other than
VRAC could have affected the changes in IOS during stimulation.
NPPB is a potent but non-selective Cl- channel blocker that has been extensively
studied (Alibrahim et al., 2013) and shown to inhibit RVD during osmotic challenges
(Kreisman and Olson, 2003). A previous study found NPPB, at the same concentration
level of this present study, can dramatically reduce cellular ATP content in hippocampal
neuron cultures (Olson and Martinho, 2006). In the hippocampus, reduced intracellular
ATP would disrupt numerous mechanisms such as K+ clearance via Na+/K+ATPase ,
glutamate uptake, and glutamate-glutamine. ATP is an important component of
glutamatergic-purinergic signaling which has been shown to regulate cellular volume in
retinal glial cells (Wurm et al., 2008). Together these findings suggest that reduced ATP
would jeopardize cellular energy demands and affect changes in IOS.
Niflumic acid also blocks or modulates a wide spectrum of ion channels
including: Ca2+-activated K+ channels (Ottolia and Toro, 1994), Ca+2-activated Clchannels (White and Aylwin, 1990; Korn et al., 1991), and a voltage-gated potassium
channels (Wang et al., 1997; Lee and Wang, 1999). Since niflumic acid is a weak acid, it
can lower intracellular pH and induce necrosis in cultured hippocampal neurons (Ding et
al., 2000), which can result in necrotic volume increase (Okada et al., 2001). However,
the dilated weak acid in this project would not have been able to induce necrosis.
Recently niflumic acid was found to only partially inhibit of swelling-activated Clcurrents and had little effect on EAA release (Abdullaev et al., 2006). These findings
indicate that niflumic acid is not ideal for studying effects of VRAC inhibition.
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DCPIB, once considered a specific VRAC inhibitor (Abdullaev et al., 2006;
Zhang et al., 2008) has been shown to inhibit several glutamate transport pathways
(Bowens et al., 2013). DCPIB exposure significantly reduced the maximum IOS and the
rates of changes for swelling and recovery. In addition, population spike amplitudes were
increased with DCPIB exposure similar to TFB-TBOA exposure. These results support
the recent evidence that DCPIB inhibits glutamate transport. Since DCPIB exposure
inhibited both VRACs and glutamate transport it is difficult to interrupt VRACs role in
stimulation-induced swelling.
VRACs contribution during stimulation-induced volume changes remains
inconclusive. Results from this study could not support or refute volume changes
associated with VRACs. It is possible that the effects of VRAC were minimized by the
various other effects the drugs had on IOS. Thus, current pharmacological agents used in
this study were insufficient for evaluating the role of VRACs during stimulation-induced
volume changes.

Conclusion
This study illuminates several mechanisms involved in swelling and volume
regulation in the hippocampus exposed to high frequency stimulation. We confirmed that
neuronal activity increases cellular volume proportional to stimulation frequency. The
cellular volume increases during stimulation are a result of both action potentials and
synaptic glutamate release. Most cellular swelling is due to glutamate uptake and
activation of NMDARs. Our experiments indicate that glutamate also plays a significant
role in volume regulation during neuronal stimulation. Although VRACs support volume
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regulation during osmotic challenges, volume recovery from stimulation-induced
swelling may not be dependent on VRACs.

Limitations and future directions
There are a number of limitations and future directions in this study. One of the
major limitations concerns IOS, which indirectly measures cellular volume by changes in
light transmission through tissue. IOS can be compromised as an indicator of cellular
volume changes by several factors including dendritic beading, cellular membrane
configuration, and mitochondrial swelling (Jarvis et al., 1999; Johnson et al., 2000).
Additionally, IOS measurements cannot distinguish among volume changes in glial cells,
neurons, or myelin. Although this study focused on neurons and glia, myelin also can
swell during stimulation. K+ accumulates in the periaxonal space that can cause Schwann
cell swelling and myelin restructuring (Kiernan et al., 1997). There also are a couple of
pharmacological limitations in this study concerning VRACs and iGluRs. The effects of
VRACs could not be thoroughly addressed with the use of different vehicles and
pharmacological agents. This limitation might be resolved in the future once the
molecular nature of VRACs has been identified (Abdullaev et al., 2006) There also is a
current absence of drugs to selective target presynaptic and postsynaptic iGluRs. It is
likely that iGluRs on neurons have different functions based on presynaptic or postsynaptic location (Pinheiro and Mulle, 2008).
Several factors were not evaluated in this study and potentially could contribute to
stimulation-induced swelling. Previous studies have shown that K+ plays a role in
glutamate-induced swelling both in cultured astrocytes (Hansson et al., 1994) and
hippocampal slices (Andrew and MacVicar, 1994; Pal et al., 2013). mGLuR, present on
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neurons and glia, exert a variety of effects on second messenger systems and ion channels
(D'Antoni et al., 2008). These receptors have been shown to activate mitogen-activated
protein kinase (Peavy and Conn, 1998) which has been shown to facilitate RVD (Crepel
et al., 1998). A study with astrocyte cultures has demonstrated that mGluRs are involved
in glutamate-induced swelling (Hansson et al., 1994). There is evidence that mGluRs
enhance glutamate uptake (Yao et al., 2005) which would contribute to stimulationinduced swelling. Some studies have suggested mGluRs influence the release of
gliotransmitters such as ATP which has been shown to regulate cellular volume (Wurm et
al., 2008). This suggests further research should examine the role of mGluRs,
gliotransmission, and purinergic signaling in stimulation-induced volume changes.
Finally, since this study demonstrated that neuronal activity affects volume
changes, modulation of that activity will regulate volume changes. The effect of
inhibitory signaling on stimulation-induced volume changes should be addressed in
future studies. A previous study in hippocampal slices demonstrated that inhibition of
GABA receptors increased IOS thus suggesting that inhibitory signals also can modulate
volume (Pal et al., 2013). Recent evidence shows that glycine and glutamate co-exist in
the hippocampus at the glutamatergic presynaptic terminals and are thought to modulate
NMDARs and decrease neuronal excitability (Muller et al., 2013). This also could
control stimulation-induced swelling.
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